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Abstract
Background: Screening and monitoring in pregnancy are strategies used by healthcare providers
to identify high-risk pregnancies so that they can provide more targeted and appropriate treatment
and follow-up care, and to monitor fetal well-being in both low- and high-risk pregnancies. The use
of many of these techniques is controversial and their ability to detect fetal compromise often
unknown. Theoretically, appropriate management of maternal and fetal risk factors and
complications that are detected in pregnancy and labour could prevent a large proportion of the
world's 3.2 million estimated annual stillbirths, as well as minimise maternal and neonatal morbidity
and mortality.
Methods: The fourth in a series of papers assessing the evidence base for prevention of stillbirths,
this paper reviews available published evidence for the impact of 14 screening and monitoring
interventions in pregnancy on stillbirth, including identification and management of high-risk
pregnancies, advanced monitoring techniques, and monitoring of labour. Using broad and specific
strategies to search PubMed and the Cochrane Library, we identified 221 relevant reviews and
studies testing screening and monitoring interventions during the antenatal and intrapartum
periods and reporting stillbirth or perinatal mortality as an outcome.
Results: We found a dearth of rigorous evidence of direct impact of any of these screening
procedures and interventions on stillbirth incidence. Observational studies testing some
interventions, including fetal movement monitoring and Doppler monitoring, showed some
evidence of impact on stillbirths in selected high-risk populations, but require larger rigourous trials
to confirm impact. Other interventions, such as amniotic fluid assessment for oligohydramnios,
appear predictive of stillbirth risk, but studies are lacking which assess the impact on perinatal
mortality of subsequent intervention based on test findings. Few rigorous studies of
cardiotocography have reported stillbirth outcomes, but steep declines in stillbirth rates have been
observed in high-income settings such as the U.S., where cardiotocography is used in conjunction
with Caesarean section for fetal distress.
Conclusion: There are numerous research gaps and large, adequately controlled trials are still
needed for most of the interventions we considered. The impact of monitoring interventions on
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stillbirth relies on use of effective and timely intervention should problems be detected. Numerous
studies indicated that positive tests were associated with increased perinatal mortality, but while
some tests had good sensitivity in detecting distress, false-positive rates were high for most tests,
and questions remain about optimal timing, frequency, and implications of testing. Few studies
included assessments of impact of subsequent intervention needed before recommending
particular monitoring strategies as a means to decrease stillbirth incidence. In high-income
countries such as the US, observational evidence suggests that widespread use of cardiotocography
with Caesarean section for fetal distress has led to significant declines in stillbirth rates. Efforts to
increase availability of Caesarean section in low-/middle-income countries should be coupled with
intrapartum monitoring technologies where resources and provider skills permit.
Introduction
Although most pregnancies progress normally, some are
more complex because of antenatal or intrapartum condi-
tions that place the mother, the developing fetus, or both
at a higher risk for complications than pregnancies with-
out these conditions. Pre-existing chronic conditions, as
well as conditions that arise during pregnancy, can
threaten the life and health of the fetus or the mother.
Maternal hypertension, diabetes mellitus, renal disease,
and autoimmune disorders, as well as placentation abnor-
malities and congenital anomalies, are examples of condi-
tions that can place the pregnancy at high risk of fetal
compromise. Fetal growth restriction arising from placen-
tal insufficiency is a significant cause of perinatal mortal-
ity (stillbirth or neonatal death) and morbidity
(complications of prematurity) internationally [1]. Addi-
tionally, if not detected and addressed promptly, fetal
hypoxia resulting from placental dysfunction or poor fetal
tolerance of labour can cause stillbirth, neonatal death, or
physical and developmental disabilities in the child [2].
Relatively non-invasive techniques exist to screen for a
number of these conditions during the antenatal and
intrapartum periods. These screening tools can also be
used to monitor fetal well-being via assessment of fetal
movement, heart rate, and/or growth; and feto-placental
and/or uteroplacental circulatory dynamics, whether rou-
tinely at antenatal care (ANC) visits or via more complex
screening tests in high-risk and post-term pregnancies [3].
Despite widespread clinical use of many of these tech-
niques, the sensitivity and predictive value of these tests
and methods are often too poor to reliably detect prob-
lems. Prompt detection of risk factors and complications
is also critical, as measures of fetal distress or compromise
associated with certain high-risk conditions may rapidly
lead to fetal demise. Certain maternal or fetal problems
may prompt the need for pharmacological intervention,
early delivery, or surgical delivery (Caesarean section)
rather than vaginal delivery. Optimising gestational age at
delivery and judicious timing of corticosteroid adminis-
tration are key challenges in responding to fetal compro-
mise arising pre-term. The appropriate use of accurate
screening and monitoring technologies can facilitate
timely referral to facilities capable of providing operative
delivery or other interventions for complications prior to
or during labour. On the other hand, screening and mon-
itoring techniques during pregnancy and the intrapartum
period could inadvertently result in avoidable perinatal
deaths, either because the technique itself is harmful or
because it increases the risk of inappropriate or unneces-
sary use of drugs, induction of labour, early delivery, or
Caesarean section.
Most studies of fetal screening and monitoring to date
have been conducted in high-resource settings. Theoreti-
cally, evidence-based screening and monitoring tech-
niques that are already in widespread use in high-income
countries could be promoted to prevent stillbirth and
other adverse pregnancy outcomes in low-/middle-
income countries. We focus here on monitoring methods
during pregnancy and the intrapartum periods, including
identification and care of high-risk pregnancies and
advanced monitoring techniques, with attention given
where relevant to the feasibility and potential impact of
implementing these techniques in low-resource settings
where most stillbirths occur.
Methods
This is the fourth in a series of papers on the evidence for
interventions that impact stillbirths. Details of the search
strategy and review procedures for this paper are described
in detail in Paper 1 of this series [4]. Each study was
assigned a level of evidence (LOE) based on its design
strength, size, and findings. The cumulative strength of
the body of evidence for each intervention was then
graded as A, B, C, or D using the SIGN grading system;
impact estimates for each intervention were further cumu-
latively assessed as having no/negative, uncertain, some
or clear evidence of benefit.
We reviewed 14 screening and monitoring interventions
for evidence of impact which are included in this paper
(Table 1). For most of these interventions, we first
reviewed studies reporting how effectively a given screen-BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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ing or monitoring test detected potential risk to the fetus
(primarily observational studies), followed by studies that
assessed the utility and/or impact of screening or monitor-
ing interventions in preventing adverse outcomes, for
which randomised controlled trials (RCTs) were most
informative.
Results
Identification and care of high-risk pregnancies
Pregnancy risk screening
Background
Early identification of high-risk pregnancies can theoreti-
cally facilitate monitoring, referral and prompt initiation
of therapy. Multiple screening and scoring systems have
been developed to assess obstetric risk generally [5,6], as
well as the risk of preterm labour, Caesarean delivery, and
other maternal and fetal outcomes. Risk scores using these
systems can range from simple additive scores to the prod-
ucts of more complex multivariable models that quantify
risk factors according to their association with adverse
outcomes [7]. An effective risk screening system, particu-
larly if convenient to implement and relatively non-
dependent on diagnostic technologies, would be particu-
larly useful in low-resource settings to help providers
identify high-risk pregnancies and refer them for appro-
priate facility-based care, and to help facilities allocate
scarce resources.
Literature-based evidence
Ten observational studies met our inclusion criteria; none
tested interventions for pregnancies scored as high-risk
(Table 2). Most risk scoring systems were originally devel-
oped and tested in high-resource settings. At a national
hospital in New Zealand, Pattison et al. [8] developed and
tested an antepartum risk scoring system (N = 29,101 con-
secutive pregnancies) using prior obstetric history and
current pregnancy risk factors, where a fetal risk score ≥ 3
denoted high risk. One-third of the total population (N =
10,859) was scored as high-risk, and 90% of those who
had a perinatal death were identified using the scoring sys-
tem. Women with an antepartum risk score of 7 or more
(very high risk) had a perinatal mortality rate of 200/
1000, whereas the low risk group of 18,242 (63%) had a
perinatal mortality rate of 4.1/1000. The system clearly
identified the population at risk of fetal or early neonatal
loss, but could not effectively predict the need for inter-
vention, as 60% of the low-risk group had a complicated
pregnancy requiring intervention [LOE: 2-]. The same
research group later used this dataset to develop a statisti-
cally derived antenatal risk scoring system using data on
27 antenatal variables from 20,985 pregnancies [9].
Tested on 3120 subsequent pregnancies, the scoring sys-
tem had a positive predictive value of 0.73 in early preg-
nancy and 0.91 at onset of labour. Although only 16% of
pregnancies were classified as high-risk at onset of labour,
87% of adverse outcomes occurred within this group. The
positive predictive value of this system was higher than
any previously reported statistically derived score, but
requires that clinicians be able to sum logistic coefficients
(basic statistical analysis), which requires more training
than some other systems [LOE: 2-].
In the UK, an effort by Chard et al. [10] to calculate obstet-
ric risk scores from individual risk factors (N = 2029 preg-
Table 1: Screening and monitoring interventions reviewed in this paper
Identification and care of high-risk pregnancies
Pregnancy risk screening
Fetal movement counting
Routine ultrasound scanning
Doppler velocimetry
Pelvimetry
Detection and management of maternal diabetes mellitus
Advanced monitoring in pregnancy 
Antenatal fetal heart rate monitoring using cardiotocography
Fetal biophysical profile test scoring
Vibroacoustic stimulation
Amniotic fluid volume assessment
Home versus hospital-based bed rest and monitoring in high-risk pregnancy
In-hospital fetal surveillance unit
Monitoring during the intrapartum period
Use of the partograph
Cardiotocography with or without pulse oximetryBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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Table 2: Impact of pregnancy risk screening on stillbirth and perinatal mortality
Source Location and Type of Study Intervention Stillbirths/Perinatal Outcomes
Observational studies
Abraham et al. 1991 [18] India. Health centre setting.
Prospective cohort study. Health 
workers at 6 primary health centres 
used a home-based mothers card 
with pregnant, mostly illiterate 
women (N = 2446).
Assessed the association of perinatal 
mortality with risk factors recorded on 
a home-based mother's card to 
pregnant women on which risk factors 
and ANC attendance were 
documented.
PMR directly related to # of risk 
factors:
0 risk factors: PMR = 25.9/1000
1 risk factor: PMR = 39.7/1000
2 risk factors: PMR = 56.5/1000
3 risk factors: PMR 122.5/1000)
Chard et al. 1992 [10] UK.
N = 994 pregnant women (470 
primiparae; 524 multiparae)
Used receiver-operating characteristic 
curves (ROC) to compare the use of 
weighted and unweighted risk scores in 
estimating an overall risk score based 
on individual risk factors, and relating 
this score to fetal outcome.
Weighted risk factor method clearly 
superior to unweighted risk factor 
method in primiparae. 
No difference in multiparae.
Cho et al. 1991 [163] Korea. Chung Ang Medical Center.
Cross-sectional study to test scoring 
system. N = 1300 pregnant women 
(N = 1313 infants) admitted from 
1988–1990.
Assessed the utility of Edwards' scoring 
system adapted to a Korean setting in 
identifying high-risk pregnancy. Risk 
scoring included demographic, 
obstetric, medical, and miscellaneous 
factors.
560 infants (42.7%) were born to 
mothers with risk-scores greater 
than 7, and 753 infants (57.3%) were 
born to mothers with risk-scores less 
than 7.
Lefevre et al. 1989 [15] USA. Rural primary care setting.
Prospective study. N = 635 women. 
N = 47 (8.3%) adverse outcomes.
Tested the predictive value of 
Coopland's obstetric risk in anticipating 
adverse outcome (perinatal death, 
birthweight < 2500 g, 5-min Apgar 
score < 7, or newborn transferred to a 
level 2 or level 3 nursery.
There was a clear relationship 
between risk score and probability of 
adverse outcome. Good sensitivity 
could be achieved only at the 
expense of a very high false-positive 
rate, however. 
Risk scoring no more effective than a 
policy that would refer all women 
with standard obstetric risk factors; 
majority of adverse outcomes 
occurred in women identified as low-
risk.
Majoko et al. 2002 [12] Zimbabwe. Rural setting.
Evaluation of screening test; sub-
study of ANC trial. N = 5223 
women who received traditional 
care from nurse-midwives in 12 rural 
health centres (N = 2890 high risk).
Used traditional risk scoring at ANC 
booking to group women into low- and 
high-risk groups. High-risk women were 
encouraged to deliver in facilities.
Complications: 924 (17.7%) of 
women; 62.4% had had risk markers 
identified at booking. 20% (577/2890) 
of women classified as high risk 
developed complications.
Predictive ability of risk allocation: 
Likelihood ratio = 1.16.
Mikulandra 1986 [164] Croatia.
Prospective study.
Assessed the associations of a risk 
factor scale (low, moderate, and high 
risk) for pregnancy and delivery on 
perinatal outcomes.
High pregnancy risk: 10.9% of cases.
High intrapartum risk: 14.02% of cases.
Severe asphyxia (Apgar ≤3): 0.37%, 
0.81%, and 4.36% in low, moderate, 
and high-risk groups, respectively (P 
< 0.001).
SBR: 0.76% vs. 34.48% in low vs. high-
risk groups (P < 0.01)
Morrison 1980 [165] USA.
Retrospective analysis. N = 1994 
consecutive parturients, N = 472 
(23%) high-risk (risk score ≥ 3).
Assessed the association of high-risk 
(risk score ≥ 3) pregnancy with adverse 
perinatal outcomes.
PMR: Significantly higher in high-risk 
group (P > 0.001).
Abnormal intrapartum outcome: 71% 
of high-risk group (P < 0.0001).
Morrison 1979 [11] USA.
N = 16,733 deliveries. Women 
scored during pregnancy using a 
simplified, numerical form for 
antepartum risk scoring.
Tested the predictive value of a 
simplified risk scoring system in 
anticipating the risk of perinatal 
mortality.
19% of group was high-risk (score ≥ 
3).
PMR: 69/1000 vs. 7/1000 in high- vs. 
low-risk groups, respectively (P < 
0.0001).
70% of perinatal deaths occurred in 
high-risk group.BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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nant women) found that risk scores were useful only for
identifying the small group of women at particularly high
risk of adverse fetal outcomes. For most women, risk
scores were uninformative [LOE: 2-].
In the USA, Morrison et al. [11] found that perinatal mor-
tality was significantly higher in the high- versus the low-
risk groups identified with the application of a simplified
risk scoring system, where high risk was a score of 3 or
greater (69/1000 versus 7/1000, respectively, P < 0.0001).
Seventy percent of perinatal deaths occurred in the high-
risk group, which was 19% of the total group screened
[LOE: 2-].
Other studies implemented risk scoring systems in more
remote or low-resource settings in low-/middle-income
countries. Attempting to predict intrapartum complica-
tions in rural Zimbabwe where most women receive care
from nurse-midwives, Majoko et al. [12] employed ante-
natal risk assessment at the first antenatal visit based on
medical and demographic measures and obstetric history
(N = 5223 women at 12 health centres). All high-risk
women (N = 2890) were encouraged to seek hospital
delivery. Of the 924 (17.7%) women who experienced
complications, 577 (62.4%) had had risk markers identi-
fied at booking; however, only 20% (577/2890) classified
as high risk developed intrapartum complications. This
risk screening system had a likelihood ratio of 1.16, indi-
cating it was ineffective in identifying women at risk of
pregnancy complications and generated too large a risk
group for referral [LOE: 2-].
In India, Talsania et al. [13,14] reported on the applica-
tion of an antenatal risk scoring system (N = 687 women),
and observed that no stillbirths occurred among women
with no identified risk factors, whereas among women in
the highest risk group, 20% had stillbirths. Perinatal mor-
tality was 84.77/1000 births, and 7.94 among the no risk
group. The perinatal mortality rate rose with level of risk,
with a rate of 92.20/1000 births for the women with mild
risks to a rate of 200/1000 for those with severe risks,
which was statistically significant. Sensitivity, specificity,
and positive predictive values for perinatal mortality were
98.3%, 19.9%, and 10.3%, respectively [LOE: 1+].
In a rural primary care setting in the USA, Lefevre et al.
[15] found a clear relationship between risk score and
probability of adverse outcome, but cautioned that good
sensitivity could be achieved only with a very high false-
positive rate, as the majority of adverse outcomes
occurred in women identified as low-risk [LOE: 2-]
In a remote area of Australia, Humphrey et al. [16]
employed pregnancy risk scoring (N = 2875 women with
singleton births), and found that during the study period,
hospital and regional perinatal mortality rates fell by
more than half. Women with low-risk scores had a statis-
tically significantly lower incidence of preterm birth, lead-
ing the authors to conclude that risk scoring can be of
benefit in allocating scarce resources [LOE: 2-].
Several other retrospective analyses attempted to associate
perinatal mortality with the presence of specific risk fac-
tors. In Guadeloupe, West Indies, using data from the
1984–85 Guadeloupean Perinatal Audit, de Caunes et al.
[17] observed that perinatal mortality was associated with
a specific combination of risk factors representing mater-
nal demographic, socioeconomic, obstetric history and
risk characteristics measurable at the first antenatal visit,
leading the authors to advocate for risk assessments spe-
cific to pregnancy outcomes within specific populations
[LOE: 3-].
Using risk screening as a strategy to facilitate monitoring
and referral, Abraham et al. [18] adapted the Home Based
Mothers Card recommended by the World Health Organ-
Talsania et al. 1994 [14] India (Ahmedabad).
N = 687 indigent women enrolled 
during first trimester. Women 
scored as no, mild, moderate, or 
severe risk based on 
sociodemographic and obstetric 
data.
Assessed association of risk factors and 
risk scoring with perinatal mortality.
PMR: 84.77/1000 births overall; 7.94 
in no risk, 92.20/1000 for mild, 200/
1000 for severe. Statistically 
significant.
PMR: OR = 13.09 in women with risk 
factors vs. women without, 
respectively.
PM sensitivity, specificity, PPV were 
98.31%, 19.90%, and 10.34% 
respectively.
Talsania et al. 1991 [13] India (Ahmedabad).
N = 687 women enrolled at < 12 
wks gestation, given risk scoring 
during their first and second visits, 
during their second and third 
trimesters, and when admitted for 
delivery.
Assessed the association of risk factors 
with perinatal mortality.
81.66% had risk factors. Women with 
no risk factors had no stillbirths, 
while 20% of those in the highest risk 
group did.
Table 2: Impact of pregnancy risk screening on stillbirth and perinatal mortality (Continued)BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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isation (WHO) for a rural Indian setting. Perinatal mortal-
ity was directly associated with number of risk factors:
perinatal mortality rates (PMRs) were higher among
women with 3 or 4 risk factors than those with 1 or 2 risk
factors [LOE: 2-].
Conclusion
A number of studies reviewed were able to successfully
identify women at high risk of obstetric complications.
However, despite good sensitivity, risk scoring systems [7]
have poor positive predictive value in anticipating adverse
birth outcomes, particularly when used well before term
or in populations significantly different from the popula-
tion in which the system was developed [19]. This limita-
tion of risk scoring systems limits the impact of their use.
No studies were found that effectively incorporated risk
screening with appropriate interventions to demonstrate a
possible impact on stillbirth or perinatal mortality rates
compared to a control group. The evidence for risk screen-
ing at the community level yielded a Grade C assessment.
Fetal movement counting
Background
Monitoring fetal movements using counting strategies is
an indirect measure of central nervous system integrity
and fetal responsiveness. Commonly employed in clinical
practice, fetal movement counting is a simple and inex-
pensive means of monitoring fetal well-being [20]. The
rationale for fetal movement counting is that decreased
fetal movements signal decreased oxygenation, which
often precedes fetal demise [1]. Kick charts or other
recording strategies involve a pregnant woman in the sec-
ond half of pregnancy monitoring fetal movements, doc-
umenting the frequency of movements she feels, and
reporting these counts to her physician. Changes in these
counts, particularly decreases, indicate possible fetal com-
promise, and thus alert care providers to the need for fur-
ther diagnostic tests such as non-stress testing or the
biophysical profile. Cessation of movement can indicate
impending fetal death, while gradual diminishment of
activity can indicate chronic fetal compromise [21]. Fetal
movement monitoring may be used routinely, or only in
high-risk pregnancies. There are many different counting
methods, and fetal movement monitoring has a wide fol-
lowing among clinicians, who perceive the practice to
serve as an early warning system for fetal compromise. A
criticism of the practice is that it may cause undue worry
for the pregnant woman [22].
Literature-based evidence
The literature search identified one Cochrane review com-
prised of three RCTs; and seven observational and inter-
vention studies (Table 3).
Several trials in high-risk pregnancies documented an
association between poor fetal movements and stillbirth/
perinatal mortality rates. A trial among high-risk women
(N = 110) by Lema [23] found that fetal movement was a
predictor of stillbirth rate, documenting differential rates
[12/1000 (1/83) versus 185/1000 (5/27) in the groups
with good versus poor fetal movements, respectively]
[LOE: 2-]. De Muylder [24] evaluated the use of a kick
chart to monitor the fetus in high-risk pregnancies, find-
ing that both stillbirth rates (SBR) and PMR increased sig-
nificantly if a previously normal chart kick chart became
abnormal (antepartum SBR = 194/1000 versus 7/1000;
and PMR = 222/1000 vs. 27/1000 in charts that became
abnormal versus normal, respectively, P < 0.001) [LOE: 2-
]. Two other observational studies found no difference in
perinatal mortality between groups with good versus poor
fetal movements measured using kick charts [25,26].
Other observational studies, RCTs, and reviews assessed
impact on perinatal mortality of interventions using kick
charts. A before-after study by Moore et al [27] introduced
formal fetal movement monitoring into clinical practice,
and stillbirth rates declined from 8.7 to 2.1/1000 over the
course of the study (χ2 = 6.8; P < 0.01). A Cochrane review
by Mangesi et al [22] included 3 trials that tested strategies
of routine kick counting, but varied study designs pre-
cluded outcome pooling (Additional file 1). Unfortu-
nately, no included trials compared fetal movement
counting with no fetal movement counting, and all stud-
ies showed nonsignificant impact on perinatal outcomes,
including stillbirth incidence. [LOE: 1++].
The largest RCT testing kick charts [28] assessed the
impact of the use of kick charts on unexplained stillbirth
in normally-formed singleton pregnancies (N = 68654),
and found no difference in rates of fetal death between
intervention and control groups (59/31993 [2.9/1000]
versus 58/36661 [2.7/1000], respectively [NS]). These
findings alone largely shaped the UK National Institute
for Health and Clinical Excellence (NICE) evidence-based
routine antenatal care guidelines, which do not recom-
mend the use of kick charts in uncomplicated pregnancy
[29][LOE: 1+]. However, of the 17 women in the study
randomised to kick charts who alerted their provider
about decreased fetal movement and subsequently deliv-
ered a stillborn baby, none had an emergency delivery, as
follow-up testing using cardiotocography resulted in false
negatives for all 17 women[30].
Conclusion
The existence of a Cochrane review of multiple RCTs [22]
yields a Grade B evidence rating. In keeping with the NICE
guidelines based largely on 1 study [28], evidence from
these studies indicates a lack of impact of fetal movement
monitoring on stillbirth or perinatal mortality. DespiteBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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Table 3: Impact of fetal movement counting on stillbirth and perinatal mortality
Source Location and Type of Study Intervention Stillbirths/Perinatal outcomes
Reviews and meta-analyses
Mangesi et al. 2007 [22] Peru, Denmark.
Meta-analysis (Cochrane). 3 RCTs 
included (N = 66 women).
Routine fetal movement counting 
(intervention) versus mixed or 
undefined fetal movement counting 
(controls).
SBR: weighted mean difference = 
0.23 [95% confidence interval (CI): 
-0.61–1.07) [NS]
[Mean (SD) = 2.90 (1.90) vs. 2.67 
(1.55) in intervention vs. control 
groups, respectively].
Intervention studies
Gomez et al. 2007 [166] Peru. Hospital setting.
RCT. Pregnant women (N = 
1400).
Compared two different charting 
methods: a novel fetal movement 
chart proposed by the Latin 
American Center for Perinatology 
(CLAP) (intervention) vs. the 
count-to-ten Cardiff chart method 
(comparison).
Fetal death (miscarriage+SB): 
Relative risk (RR) not estimable.
[0/700 in both groups].
Grant et al. 1989 [28] UK, USA, Ireland, Sweden, 
Belgium.
Cluster RCT. 66 clusters. Pregnant 
women (N = 68654 women; N = 
31993 intervention, N = 36661 
controls).
Compared the impact on birth 
outcomes of asking mothers to 
keep routine kick charts 
(intervention) vs. not keeping kick 
charts (controls).
Unexplained late antepartum fetal 
death: 59/31993 (2.9/1000) vs. 58/
36661 (2.7/1000) in intervention 
vs. control groups, respectively 
[NS].
Moore 1989 [27] USA. Hospital setting.
Before-after pilot study (N = 2519 
deliveries before intervention, N = 
1864 after introduction of 
intervention.)
Assessed the impact of introducing 
formal fetal movement assessment 
(intervention) compared to no 
monitoring before the intervention 
(controls).
Fetal death (miscarriage+SB): 2.1/
1000 vs. 8.7/1000 after vs. before, 
respectively. (χ2 = 6.8; P < 0.01)
Observational studies
De Muylder et al. 1988 [24] Zimbabwe. Hospital setting.
Prospective cohort study. High-
risk pregnant women (N = 200).
Compared the obstetrical 
outcome among the patients with a 
normal kick chart (unexposed), 
compared to those with an 
abnormal count (exposed).
SBR: 19.4% vs. 0.7% in charts that 
went from normal to being 
abnormal vs. unexposed. (P < 
0.001)
PMR: 22.2% vs. 2.7% for previously 
normal charts that became 
abnormal vs. unexposed (P < 
0.001)
Lema 1988 [23] Kenya. Urban hospital setting.
Prospective cohort study. High-
risk pregnant women (N = 110).
Compared birth outcomes among 
women with good fetal movements 
vs. poor fetal movements.
SBR: 12/1000 (1/83) vs 185/1000 
(5/27) in the good vs. poor fetal 
movements group, respectively. 
No statistical significance data.
Sinha et al. 2007 [25] UK. Hospital setting.
Retrospective cohort study. N = 
180 case reports.
Compared the impact of reduced 
fetal movements (exposed) to 
women without reduced fetal 
movements (unexposed) on PMR.
PMR: RR not estimable.
[0/90 in the exposed vs. 0/90 in the 
control groups, respectively].
Intervention needed solely due to 
fetal compromise: 29/90 (32%) in 
the study vs. 19/90 (21%) in the 
control groups, respectively.
Romero Gutiérrez et al. 1994 [26] Mexico. Hospital setting.
Prospective cohort study. 
Pregnant women (N = 200; N = 
100 intervention, N = 100 
controls) 32–41 wks gestation 
without risk factors.
Compared the impact of decreased 
fetal movement (exposed) vs. 
normal fetal movement 
(unexposed) on PMR.
PMR: No difference [NS]BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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indirect evidence that formal movement monitoring
using a counting method is more effective than mothers'
subjective assessments of fetal movement in identifying
babies at risk of intrauterine death, false negatives on sub-
sequent fetal assessment tests and clinical error may be
responsible for the lack of impact on perinatal mortality,
as suggested by Del Mar et al [30]. Monitoring does
appear to be of some value in high-risk pregnancies
[23,24], particularly those in which there is suspicion of
placental insufficiency. Routine fetal movement monitor-
ing is currently recommended only for high-risk pregnan-
cies, particularly those in which there is clinical suspicion
of restricted fetal growth or placental dysfunction revealed
through ultrasonographic or Doppler studies. Further
studies are warranted to determine which methods of fetal
movement counting prove most effective in identifying
complications (sensitivity and specificity) early enough
for interventions to prevent stillbirth, as well as accepta-
bility to and feasibility for women. Universal fetal move-
ment monitoring for all pregnancies is unsupported by
scientific evidence.
Routine use of ultrasound scanning
Background
Ultrasound scans during pregnancy are widely used, even
in many resource-poor settings, but availability and qual-
ity of ultrasound machines vary, and ultrasound operators
in some settings may lack the ability to accurately inter-
pret imaging. Diagnostic ultrasound examination may be
employed to date pregnancies, identify multiple pregnan-
cies, document placental location, identify fetal anoma-
lies (particularly when the fetus is suspected to be at high
risk of malformation), identify fetal growth restriction or
abnormal amniotic fluid volume, or to investigate clinical
complications (e.g., bleeding). Some clinicians have pos-
tulated that routine use of ultrasound in all pregnancies
could identify problems in asymptomatic pregnancies,
whether early or late in gestation [31].
Literature-based evidence
We identified two Cochrane reviews and five other inter-
vention/observational studies; we also conducted an
independent meta-analysis incorporating 9 RCTs (Table
4).
One observational study of routine ultrasound use sug-
gested that ultrasound may help to identify some high-
risk pregnancies. In Egypt, Mahran et al [32] reported that
routine ultrasound was superior to fundal palpation in
identifying fetal growth restriction (89.7% versus 34.7%
of growth-restricted infants identified accurately with each
method, respectively). No observational studies reported
any statistically significant impact of routine ultrasound
scanning on subsequent stillbirth rates. A Cochrane
review on the impact of ultrasound during pregnancy is in
progress [33].
Another Cochrane review by Neilson [31] reviewed ade-
quately controlled trials of routine ultrasound imaging in
early pregnancy (N = 9) (Additional file 2). The study
found that routine ultrasound examination was associ-
ated with earlier detection of multiple pregnancies and
reduced rates of induction of labour for post-term preg-
nancy, but ultrasound had no impact on PMR [Odds ratio
(OR) = 0.86, 95% confidence interval (CI): 0.67–1.12],
even in twin pregnancies, despite generally earlier diagno-
sis in the ultrasound-screened pregnancies. Where detec-
tion of fetal abnormality was a specific aim of the
examination, ultrasound was associated with increased
terminations of pregnancy [LOE: 1+]
A second Cochrane review by Bricker et al. [34] assessed
the impact of ultrasound in late pregnancy (8 RCTs, N =
27,024 women) and found no difference in antenatal,
intrapartum and neonatal intervention or morbidity in
those undergoing ultrasound screening versus those not
screened (Additional file 3). The Caesarean section rate
was slightly higher among the screened group, but this
difference did not reach statistical significance. Routine
late pregnancy ultrasound was not associated with
improvements in overall perinatal mortality. 
An additional RCT (N = 1528 women) from New Zealand
by Duff et al. [35] documented a statistically non-signifi-
cant increase in SBR among women scanned twice during
pregnancy, at 16–24 weeks and again at 32–36 weeks ges-
tation [LOE: 2+]. In another RCT by Proud et al [36]
where placental grading information from ultrasound
screening was either given to a clinician (intervention) or
withheld (controls), the antepartum SBR (excluding
lethal malformations) was 0/1014 versus 9/1011 among
intervention versus controls, respectively (P < 0.05) [LOE:
2+].
New meta-analysis
We also conducted an independent, new meta-analysis for
the purposes of this review, as we identified 9 RCTs (N =
35,049 women) reporting an impact on perinatal mortal-
ity rate of ultrasound in early pregnancy versus no or
selective use of ultrasound in early pregnancy (before 24
weeks) (Figure 1). We found no significant difference
between the 2 groups when the results were pooled (OR =
0.89, 95% CI: 0.70–1.14).
Conclusion
There is no clear evidence that ultrasound examination
during pregnancy is harmful [31], and its assumed bene-
fits include (1) better gestational age assessment; (2) ear-
lier detection of multiple pregnancies; (3) determinationBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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of placental location to rule out placenta praevia; (4)
detection of clinically unsuspected fetal malformation
when termination of pregnancy is more feasible, and (5)
monitoring of fetal growth for pregnancies at increased
risk of fetal growth restriction or macrosomia. The
reduced incidence of induction of labour for apparent
Table 4: Impact of use of routine ultrasound scanning on stillbirth and perinatal mortality
Source Location and Type of Study Intervention Stillbirths/Perinatal Outcomes
Reviews and meta-analyses
Bricker et al. 2008 [34] New Zealand), Norway (Trondheim), 
Australia, UK (Peterborough), USA.
Meta-analysis (Cochrane). 8 RCTs 
included (N = 21,708 women).
Assessed the effects of routine 
ultrasound > 24 wks (intervention) 
vs. no/concealed/selective 
ultrasound > 24 wks (control).
SBR: RR = 1.11 (95% CI: 0.29–4.26) 
[NS]
[45/10894 vs. 38/10814 in 
intervention vs. control groups, 
respectively].
PMR: R = 0.94 (95% CI: 0.55-1.64) 
[NS]
[79/12198 vs. 75/12078 in 
intervention vs. control groups, 
respectively.]
Neilson 1998 [31] Finland, UK, USA, Sweden, Trondheim, 
South Africa.
Meta-analysis (Cochrane). 8 RCTs 
included (N = 34,245).
Assessed the effects of routine 
ultrasound (intervention) vs. the 
selective use of ultrasound 
(control) in early pregnancy (i.e. < 
24 wks).
PMR: OR = 0.86 (95% CI: 0.67–1.12)
Intervention studies
van Dyk et al. 2007 [167] South Africa.
Open cluster RCT. Pregnant women (N 
= 804).
Compared the impact of ultrasound 
screening (intervention) vs. no 
ultrasound (controls).
PMR: RR = 1.05 (95% CI: 0.54–2.03, 
P = 0.88.) [NS]
[18/416 (4.3%) vs. 16/388 (4.1%) in 
intervention vs. control groups, 
respectively].
Observational studies
Cristina et al. 2005 [168] Spain.
Retrospective (case-control) review of all 
obstetric ultrasounds. Pregnant patients 
(N = 5,987 examined by ultrasound scan 
at 20 wks; N = 40 cases with a single 
umbilical artery, N = 82 controls).
Compared the impact of having a 
single umbilical artery (cases) vs. 
not having this condition (controls) 
as diagnosed by ultrasound scan on 
PMR.
PMR: 5% (2/40) among single uterine 
artery cases (10× greater than 
overall patient rate). No statistical 
significance data.
Mahran et al. 1992 [32] Egypt. Tertiary care setting.
Comparison of diagnostic tests. Pregnant 
women (N = 828), of whom a 
proportion had growth-restricted 
neonates (N = 98).
Compared the effectiveness of 
diagnostic ultrasound (intervention) 
vs. fundal palpation (controls) in 
predicting growth restriction.
Growth restriction: 89.7% (88/98) vs. 
34.7% (34/98) detection rate in 
ultrasound vs. fundal palpation 
groups, respectively.
Sylvan et al. 2005 [169] Sweden. University clinics.
Observational cohort study. Deliveries 
from 1985–1996; stored data (N = 
209,726).
Compared the impact of routine 
ultrasound screening (exposed 
group) vs. no routine screening 
(unexposed) in third trimester on 
PMR.
PMR: [NS]
[160/56,371 vs. 488/153,355 in 
exposed vs. unexposed, 
respectively.]
Viero et al. 2004 [170] Canada.
Observational study. Structurally and 
chromosomally normal singleton 
pregnancies (N = 60) with abnormal 
fetoplacental blood flow < 32 wks of 
gestation; N = 21 of these resulted in 
stillbirth and were delivered vaginally.
To assess the ability of grayscale 
placental ultrasound to detect 
pathological lesions in the placentas 
of pre-term pregnancies.
SB: charts with both abnormal 
uterine artery Doppler and abnormal 
grayscale findings strongly predictive 
of stillbirth (17/21 SBs; sensitivity 
81%, PPV 52%, P = 0.006).BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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post-term pregnancy in the routinely scanned groups pre-
sumably results from better gestational age dating, and
twin pregnancies being detected earlier. Neither of these
effects has been shown to improve fetal outcome, but
much larger numbers of participants would be required to
accurately measure this outcome.
Based on the results of 2 Cochrane reviews, our meta-anal-
ysis, and other RCTs (overall Grade B evidence), there is
no evidence that routine ultrasonography has any impact
on perinatal mortality compared to the selective use of
ultrasonography based on clinician judgement. It may be
that routine ultrasound cannot reliably detect complica-
tions, or that high rates of false positives expose higher
numbers of babies to iatrogenic intervention (particularly
the risk of iatrogenic preterm birth in the event of inaccu-
rate gestational age dating). The routine use of early ultra-
sonography in pregnancy cannot be recommended to
prevent stillbirth, as there is no evidence of its benefit in
preventing stillbirth or perinatal mortality. There is a need
for decision analysis studies subsequent to diagnostic
ultrasound, like the study of indicated Caesarean section
for fetal macrosomia diagnosed by ultrasound by Rouse et
al [37], but which report perinatal mortality outcomes.
Clinics and hospitals, particularly those in resource-con-
strained settings, must assess whether the potential bene-
fits are worth the cost of routine ultrasound screening for
all pregnant women.
Doppler velocimetry
Background
In many high-income countries, Doppler ultrasound
studies are used as a non-invasive means to assess the suf-
ficiency of uterine and umbilical cord blood flow. These
velocimetry studies can improve management of pregnan-
cies by aiding identification of fetuses at highest risk of
adverse outcomes associated with pre-eclampsia, fetal
growth restriction, and congenital malformations. Man-
agement of pre-term pregnancies with signs of fetal
growth restriction and pre-eclampsia is complex, espe-
cially before 32 weeks gestation. The risk of prolonged
hypoxia and acidaemia leading to stillbirth or neonatal
death if the pregnancy is allowed to progress must be bal-
anced against the risks of neonatal morbidity and mortal-
ity associated with prematurity if early delivery is chosen.
Doppler ultrasonographic evaluation may aid determina-
tions of the degree to which the fetus may be or become
compromised.
Early in normal pregnancy, trophoblasts invade the
maternal uterine spiral arteries and reduce resistance to
uterine blood flow. Impeded flow measured by uterine
artery Doppler suggests a failure of this trophoblastic
invasion, which is associated with subsequent pre-
eclampsia, fetal growth restriction, and stillbirth [38].
Uterine artery Doppler studies could therefore be helpful
in identifying women likely to develop pre-eclampsia or
to have a growth-restricted fetus [39].
Observational Doppler studies of the umbilical artery,
first conducted in the 1970s, consistently showed a corre-
lation between extremely abnormal waveforms and
adverse outcomes, including fetal growth restriction and
stillbirth [40-42]. In growth-restricted fetuses, results of
umbilical and fetal Doppler waveform analyses suggest
progressive severity of fetal compromise [38,43]. Initially,
Forest plot of results of meta-analysis of perinatal mortality rates in women examined by routine vs. selective ultrasound in  early pregnancy Figure 1
Forest plot of results of meta-analysis of perinatal mortality rates in women examined by routine vs. selective 
ultrasound in early pregnancy.
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umbilical artery velocity waveforms show increased resist-
ance; subsequent deterioration is indicated by absent or
even reversed end diastolic flow in the umbilical artery.
Later, fetal middle cerebral artery flow shows decreased
resistance, indicating brain sparing, and eventually,
abnormal venous Doppler results (ductus venosus wave-
forms and umbilical vein pulsatility) suggest fetal cardiac
dysfunction. Consequent central nervous system damage
then manifests as non-reactive results to fetal tests of well-
being, but there is wide variability in the timeline of fetal
progression to severe compromise [38,43].
Despite these well-established markers of fetal compro-
mise in Doppler testing, it is not clear whether abnormal
results of different modalities of Doppler ultrasound lead
to improved perinatal outcomes and prevention of still-
births, nor are the most appropriate indications and tim-
ing of testing known. Additionally, if a fetus is not
seriously compromised, Doppler ultrasound may poten-
tially cause iatrogenic harm in suggesting the need for
inappropriate early delivery.
Literature-based evidence
The literature search identified three systematic reviews,
one Cochrane protocol, and 10 other intervention/obser-
vational studies (Table 5 and Table 6).
Uterine artery Doppler waveform analysis
Several studies assessed whether uterine artery Doppler
velocimetry in unselected populations could identify
high-risk pregnancies, particularly those at risk of still-
birth. In a systematic review, Papageorghiou et al [44]
reviewed 15 studies of routine Doppler assessments in
pregnancy in unselected populations, and found that
Table 5: Impact of uterine artery Doppler velocimetry on stillbirth and perinatal mortality
Source Location and Type of Study Intervention Stillbirths/Perinatal 
Outcomes
Reviews and meta-analyses
Papageorghiou et al. 2002 [44] Multiple sites.
Review. 15 studies of routine 
Doppler assessments in pregnancy 
in unselected populations.
Sought to relate the risk of 
antepartum stillbirth to uterine 
artery Doppler flow velocimetry at 
22–24 weeks.
Fetal growth restriction and 
perinatal death associated with 
impeded uterine artery flow.
Positive Doppler diagnosis 
appropriately identified ~40% of 
women who subsequently 
developed pre-eclampsia (6-fold 
increased risk with positive 
Doppler) and ~20% of fetal growth 
restriction cases (3.5-fold 
increased risk)
Intervention studies
Subtil et al; Essai Régional Aspirine 
Mère-Enfant (ERASME) 
Collaborative Group 2003. [46]
France and Belgium.
Multicentre RCT. Nulliparous 
women (N = 1853; N = 1253 
intervention, N = 617 controls) 
14–20 wks gestation.
Compared the impact of uterine 
Doppler (intervention) versus 
placebo (controls) on PMR. 
Women with abnormal Doppler 
waveforms received 100 mg of 
aspirin daily from Doppler exam 
until 36 wks.
PMR: RR = 4.02 (95% CI: 0.5–32.0) 
[NS]
[8/1249 (0.6%) vs. 1/327 (0.2%) in 
intervention vs. control groups, 
respectively].
Observational studies
Smith et al. 2007 [45] UK.
Observational study. Unselected 
women (N = 30,519) who had 
uterine artery Doppler performed 
22–24 wks of gestation.
Studied the relationship between 
abnormal (mean pulsatility index in 
the top decile and a bilateral 
notch) vs. normal Doppler flow on 
the risk of antepartum stillbirth.
Antepartum SBR: adj. HR = 5.5 
(95% CI: 2.8–10.6) in Doppler with 
mean pulsatility index in the top 
decile vs. controls.
Antepartum SBR: adj. HR = 3.9 
(95% CI: 2.0–7.8) in Doppler with 
a bilateral notch versus controls.
Unexplained SBR: adj. HR 2.5 (95% 
CI: 1.1–5.6) in Doppler with mean 
pulsatility index in the top decile 
vs. controls. No association 
between Doppler with a bilateral 
notch and SB.BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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Table 6: Impact of umbilical artery and ductus venosus Doppler velocimetry on stillbirth and perinatal mortality
Source Location and Type of Study Intervention Stillbirths/Perinatal 
Outcomes
Reviews and meta-analyses
Baschat et al. 2004 [49] Germany, Netherlands, UK, USA, 
Spain, Sweden.  Review. 8 studies 
included.  N = 320 fetuses with 
normal Doppler, N = 202 with 
elevated ductus venosus (DV) 
Doppler indices (N = 101 with 
umbilical artery absent or reversed 
end-diastolic flow (UA A/REDV), 
N = 34 with DV reversed atrial 
velocity (DV-RAV).  
Assessed association of umbilical 
artery Doppler and ductus 
venosus Doppler with perinatal 
outcome in preterm growth-
restricted fetuses.
Perinatal mortality was 5.6% (16/
282) with normal DV, 11.9% (12/
101) with UA A/REDV, 38.8% (64/
165) with abnormal DV and 41.2% 
(7/17) with DV-RAV
Alfirevic and Neilson 1996 [50] Australia, Sweden, UK (Chester, 
Edinburgh), South Africa 
(Tygerberg), Ireland (Dublin), 
Netherlands (Maastricht).
Meta-analysis (Cochrane). 11 
RCTs included (N = 6753 high-risk 
pregnant women).
Assessed the effects of Doppler 
umbilical artery waveform analysis 
(intervention) vs. no Doppler 
(controls) on obstetric care and 
fetal outcomes.
SBR: OR = 0.79 (95% CI: 0.46–
1.34) [NS]
[24/3325 vs. 31/3428 in 
intervention vs. control groups, 
respectively].
PMR: OR = 0.71 (95% CI: 0.50–
1.01) [NS]
[53/3433 vs. 75/3532 in 
intervention vs. control groups, 
respectively].
Intervention studies
Baschat et al. 2003 [47] Germany.
Prospective cohort. N = 224 
pregnancies with growth-
restricted fetuses <37 weeks 
gestation.
Used logistic regression to assess 
the predictive ability of Doppler 
diagnosis of absent or reversed 
umbilical artery end-diastolic 
velocity, absence or reversal of 
atrial systolic blood flow velocity in 
the ductus venosus and pulsatile 
flow in the umbilical vein to 
predict stillbirth and perinatal 
mortality.
PMR: Umbilical artery waveform 
analysis most predictive compared 
to other Doppler modalities (R2 = 
0.49, P < 0.001)
SBR: Umbilical artery waveform 
analysis most predictive compared 
to other Doppler modalities(R2 = 
0.48, P < 0.001).
In cases of abnormal or reversed 
end-diastolic umbilical artery flow, 
venous pulsatility improved 
prediction of stillbirth.
Giles et al; DAMP Study Group 
2003 [52]
Australia, New Zealand, Southeast 
Asia. Tertiary level referral 
hospitals.
Multi-centre RCT. Pregnant 
women (N = 526) with twin 
pregnancies at 25 wks gestation.
Compared the impact of Doppler 
ultrasound umbilical artery flow 
velocity waveform analysis 
(intervention) vs. no Doppler 
(controls) on pregnancy outcomes. 
Standard ultrasound biometric 
assessment in both arms.
Fetal death (miscarriage + SB): OR 
= 0.14 (95% CI: 0.01–1.31) [NS]
[0/262 vs. 3/264 in intervention vs. 
control groups, respectively.
PMR: 9/1000 vs. 11/1000 live births 
in intervention vs. control groups, 
respectively [NS]
No authors listed 1997. [171] France. 20 centres.
Multicentre RCT. Low risk 
pregnant women (N = 3898) at 28 
wks of gestation.
Compared the impact of umbilical 
Doppler 28–34 wks gestation 
(intervention) vs. no routine 
umbilical Doppler except in cases 
of clinical indication (controls).
SBR: OR = 0.40 (95% CI: 0.04–
2.44) [NS]
[2/1948 vs. 5/1943 in intervention 
vs. control groups, respectively].
PMR: OR = 0.33 (95% CI: 0.06–
1.33) [NS]
[3/1948 vs. 9/1943 in intervention 
vs. control groups, respectively].BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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increased impedance to uterine artery flow was associated
with increased risk of pre-eclampsia, fetal growth restric-
tion and perinatal death, and that Doppler diagnosis of
impeded artery flow appropriately identified ~40% of
women who subsequently developed pre-eclampsia (6-
fold increased risk with positive Doppler) and ~20% of
fetal growth restriction cases (3.5-fold increased risk)
[LOE: 1+] (Additional file 4).
Smith et al [45] reported a statistically significantly
increased risk of antepartum stillbirth among women
whose uterine artery Doppler flow velocimetry at 22–24
weeks had a pulsatility index in the top decile [adjusted
Hazard Ratio (HR) = 5.5, 95% CI: 2.8–10.6] and among
those with a bilateral notch (adjusted HR = 3.9, 95% CI:
2.0–7.8), compared with controls with normal Doppler
flow [LOE: 2-].
An intervention RCT attempting to use Doppler in inter-
ventions to reduce rates of pre-eclampsia in France and
Belgium by the Essai Régional Aspirine Mère-Enfant
(ERASME) Collaborative Group [46] randomised women
to either uterine Doppler (N = 1253) or placebo (N =
617). Women with abnormal waveforms in the interven-
tion group were given low-dose aspirin to prevent pre-
eclampsia; but despite the aspirin prescription, rates of
Davies et al. 1992 [172] UK (London). Single centre; 
unselected population.
RCT. Singleton pregnancies (N = 
2600) > 20 wks gestation.
Compared the impact of routine 
umbilical and uterine artery 
Doppler ultrasound to assess 
placental perfusion (intervention) 
vs. no Doppler (controls) on 
pregnancy outcomes. Standard 
ANC in both arms.
SBR: 11/1246 vs. 4/1229 in 
intervention vs. control groups, 
respectively.
PMR (uncorrected): RR = 2.4 (95% 
CI: 1.00–5.76) [NS]
[17/1246 vs. 7/1229 in intervention 
vs. control groups, respectively].
PMR (normally formed): RR = 3.95 
(95% CI: 1.32–11.77).
[16/1246 vs. 4/1229 in intervention 
vs. control groups, respectively].
Whittle et al. 1994 [173] UK (Glasgow).
RCT. Singleton pregnancies (N = 
2986) < 26 wks gestation at 1st 
ANC visit. Doppler ultrasound at 
26–30 wks and 34–36 wks 
gestation in all women.
Compared the impact of umbilical 
artery Doppler ultrasound 
revealed to clinician (intervention) 
vs. concealed from clinician 
(controls).
SBR: OR = 0.34 (95% CI: 0.10–
1.07) [NS]
[3 vs. 8 in intervention vs. control 
groups, respectively.]
Observational studies
Hugo et al. 2007 [48] South Africa (Cape Town). 
Secondary hospital.
Case series. Singleton pregnant 
women (N = 572) referred for 
suspected poor fetal growth.
Investigated the use of a personal 
computer- based, continuous-
wave Doppler machine by a 
trained midwife to assess umbilical 
artery flow velocity waveforms 
with respect to the resistance 
indices (RIs).
PMR:
[RIs < P75]: 13.2
[RIs: P75-95]: 39.1
[RIs > P95]: 41.7
SGA (%):
[RIs < P75]: 27.2%
[RIs: P75-95]: 41.2%
[Ris > P95]: 55.6%
Theron et al. 1992 [41] South Africa.
Prospective cohort study. 
Pregnant women (N = 127) with 
poor symphysis fundal growth (N 
= 39 abnormal Doppler flow 
velocimetry, N = 88 normal 
velocimetry).
Compared the impact of poor 
Doppler flow velocimetry of 
umbilical artery (exposed) with 
normal flow (unexposed).
PMR: OR = 33.2 (95% CI: 6.6–
109.6; P < 0.000001).
[43.6% vs. 2.3% in exposed vs. 
unexposed groups, respectively].
Fetal death (miscarriage + SB):
[28.2% vs. 0% in exposed vs. 
unexposed groups, respectively; (P 
< 0.0005)].
Torres et al. 1995 [42] Spain (Barcelona). Hospital Clinic.
Prospective observational study 
over a 2-year period. Hypertensive 
pregnant women (N = 172; N = 
166 with live births, N = 6 fetal 
deaths).
Assessed the use of umbilical 
artery Doppler in predicting SB. 
Compared the impact of absent 
(exposed) vs. normal end-diastolic 
velocity (unexposed).
SB: All had absence of end-diastolic 
velocity (sensitivity 100%).
Fetal death (miscarriage + SB): 6/9 
vs. 0/163 in absent vs. normal flow.
Absent end-diastolic velocity in 
predicting fetal death: sensitivity: 
100%, specificity: 98.2%, positive 
predictive value 66.7%, negative 
predictive value 100%.
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pre-eclampsia were similar in the Doppler and placebo
groups (28/1237 [2.3%] versus 9/616 [1.5%], respec-
tively; RR = 1.55, 95% CI: 0.7–3.3 [NS]). The study found
a non-significant elevated impact on perinatal mortality
among Doppler-assessed fetuses compared to those
whose mothers were given placebo (RR = 4.02; 95% CI:
0.5–32.0 [NS]).
Umbilical artery and venous Doppler waveform analysis
Baschat et al [47] performed umbilical artery and venous
Doppler velocimetry in preterm growth-retarded fetuses
(N = 224) to evaluate whether absent or reversed umbili-
cal end-diastolic velocity, absence or reversed atrial systo-
lic blood flow velocity in the ductus venosus, or pulsatile
flow in the umbilical vein could predict stillbirth or peri-
natal death before 37 weeks' gestational age. Logistic
regression analysis showed that umbilical artery wave-
form analysis was the Doppler application most predic-
tive of perinatal mortality (R2 = 0.49, P < 0.001) and
stillbirth (R2 = 0.48, P < 0.001). In fetuses with absent or
reversed umbilical end flow, prediction of asphyxia and
stillbirth was significantly enhanced by venous Doppler.
Umbilical artery waveform analysis offered the highest
sensitivity and negative predictive value, whereas ductus
venosus and umbilical vein flow studies had the best spe-
cificity and positive predictive values for perinatal death
[LOE: 1+].
Using personal computer-based, continuous-wave Dop-
pler machines to assess umbilical artery flow velocity
waveforms in women referred for suspected fetal growth
restriction, Hugo et al. [48] found a direct association
between resistance indices (RIs) and perinatal mortality
rate (PMR) (PMRs of 13.2, 39.1 and 41.7 for women with
RIs < P75, P75-95 and > P95, respectively) [LOE: 3].
Baschat et al. [49] conducted a review of studies (N = 8)
where umbilical artery and ductus venosus Doppler stud-
ies were used to make decisions regarding delivery timing
in pre-term growth-restricted fetuses (Additional file 5).
One analysis in the review compared outcomes among
fetuses with normal ductus venosus indices (N = 302)
with fetuses with elevated ductus venosus index (N =
202), of whom N = 101 had absent or reversed umbilical
end-diastolic flow and N = 34 had absence or reversal of
atrial velocity in the ductus venosus. Perinatal mortality
was 5.6% (16/282) among fetuses with normal Doppler,
versus 11.9% (12/101) with absent or reversed umbilical
end-diastolic flow, 38.8% (64/165) with abnormal duc-
tus venosus index and 41.2% (7/17) with reversed atrial
velocity in the ductus venosus. Abnormal ductus venosus
results (N = 3 studies) effectively identified fetuses at risk
of stillbirth at least 1 week prior to delivery, independent
of umbilical artery waveform results, though questions
remain about optimal delivery timing in growth-restricted
pre-term fetuses [LOE: 1+].
Recently, researchers have focused on downstream impact
on perinatal mortality of the use of umbilical artery Dop-
pler ultrasound followed by appropriate interventions for
the identified conditions. A Cochrane review by Neilson
et al. [50] reviewed 11 RCTs (~7000 women) of Doppler
ultrasound investigating umbilical artery waveforms in
high-risk pregnancies. Compared to no Doppler ultra-
sound, evaluation with umbilical artery Doppler ultra-
sound in complicated pregnancies (especially with
hypertension or presumed growth restriction) was associ-
ated with a non-significant trend toward lower perinatal
mortality (OR = 0.71, 95% CI: 0.50–1.01) and stillbirth
risk (OR = 0.79, 95% CI: 0.46–1.34), as well as signifi-
cantly fewer inductions of labour (OR = 0.83, 95% CI:
0.74–0.93) and hospital admissions (OR = 0.56, 95% CI:
0.43–0.72) (Additional file 6). Whether a woman had
received Doppler ultrasound was unassociated with fetal
distress in labour or Caesarean section rates [LOE: 1+]. A
Cochrane protocol by Alfirevic et al indicates that a review
is in progress to assess whether the use of umbilical artery,
middle cerebral artery, and ductus venosus Doppler
velocimetry improves subsequent obstetric care and fetal
outcome [51].
Umbilical artery Doppler alone may not be any more
effective than routine ultrasonography in some diagnostic
assessments of fetal growth. An RCT of Doppler in twin
pregnancies in New Zealand, Australia and Southeast Asia
where all pregnancies were studied ultrasonographically
to monitor fetal growth showed no statistically significant
difference in perinatal mortality between groups on which
umbilical artery Doppler was performed versus those with
no Doppler [52].
Conclusion
Doppler ultrasound is a relatively new technique that has
been applied to the study of fetal, placental and uterine
circulatory dynamics. Despite its novelty, it has been eval-
uated by more RCTs than has any other biophysical test of
fetal growth or well-being. In low-risk or unselected pop-
ulations, there is little evidence that any form of routine
Doppler velocimetry contributes to reductions in stillbirth
rates (overall Grade C evidence). This lack of impact may
be complex: Doppler ultrasound may not identify a suffi-
cient proportion of flow abnormalities to measurably
impact stillbirth incidence; Doppler-detected abnormali-
ties may not be subsequently monitored appropriately
with other tests of fetal well-being and serial Doppler test-
ing; intervention based on abnormal Doppler may not
work; or high rates of false-positives may unnecessarily
expose the fetus to the risk of preterm birth, particularly if
gestational age dating is inaccurate. Additionally, mostBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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existing studies are underpowered to detect small impacts
on perinatal or maternal outcomes.
Uterine artery Doppler waveform analysis accurately iden-
tifies compromised fetuses at risk of stillbirth, especially
in cases of placental underperfusion associated with pre-
eclampsia and/or growth restriction, but no studies have
shown any ability of subsequent intervention to prevent
stillbirth. More studies are needed into the optimal timing
of monitoring and intervention in cases of abnormal uter-
ine artery waveforms.
Of all Doppler diagnostic studies of the fetus, umbilical
artery and ductus venosus Doppler velocimetry are most
predictive of fetal compromise associated with fetal
growth restriction, and there is some evidence that timely
and appropriate intervention for abnormal umbilical
artery or ductus venosus waveforms can prevent stillbirths
[53]. More evidence should soon be available: in addition
to the Cochrane review of umbilical and fetal Doppler
velocimetry, results are forthcoming of the multi-centre
Trial of Umbilical and Fetal Flow in Europe (TRUFFLE)
group, an RCT of timing of delivery in early pre-term fetal
growth restriction based on early and late fetal Doppler
venous changes versus cardiotocography. Such studies
may shed light on the most appropriate and effective
methods of fetal surveillance and optimal uses of Doppler
velocimetry, including multi-vessel analysis [54].
Further studies are needed to assess whether such decision
analytical models based on Doppler and other fetal sur-
veillance findings for fetal growth restriction, pre-eclamp-
sia, or congenital abnormalities could have any impact on
stillbirths. Further research might also investigate other
applications of Doppler velocimetry, including identify-
ing women who should be given other screening tests, the
comparative efficacy of Doppler versus other fetal surveil-
lance methods, and contributing to the study of the
pathophysiology of impaired placentation, uteroplacental
and fetoplacental haemodynamics, and pre-eclampsia.
Pelvimetry
Background
Pelvimetry, or pelvic measurement in pregnant women
with the intention of predicting likely cephalopelvic dis-
proproportion of cephalic presentations (and thus their
subsequent need for Caesarean section), can be per-
formed by clinical manual examination, or with imaging
techniques including conventional x-ray, computerised
tomography scanning, or magnetic resonance imaging.
Successful detection and management of cephalopelvic
disproportion is thought to reduce the risk of obstructed
labour and intrapartum stillbirth.
Literature-based evidence
We identified 1 Cochrane review and 1 other observa-
tional study of pelvimetry reporting perinatal outcomes
(Table 7). The observational study by Fine et al [55] retro-
spectively analysed studies of x-ray pelvimetry (N = 100
trials) in cephalic presentations, comparing 3 prognostic
indicators for vaginal delivery: the Thoms method, the
modified Ball technique, and manual assessment. Neither
pelvimetric method was significantly more accurate than
manual assessment of the pelvis in predicting obstetric
outcome, nor was any one method superior to the other.
When implemented as part of a strategy of pregnancy
management, pelvimetry appears to have no impact on
stillbirth. A Cochrane review by Pattinson et al. [56]
assessed RCTs implementing x-ray pelvimetry in cephalic
Table 7: Impact of pelvimetry on stillbirth and perinatal outcomes
Source Location and Type of Study Intervention Stillbirths/Perinatal Outcomes
Reviews and meta-analyses
Pattinson et al. 1997 [56] South Africa, U.S.A.
Meta-analysis (Cochrane). 4 
RCTs included (N = 895 
women).
Assessed the effects of pelvimetry 
performed antenatally, intrapartum or 
postpartum (intervention) vs. no 
pelvimetry (controls) on PMR.
PMR: OR = 0.51 (95% CI: 0.18–1.42) [NS].
[5/449 vs. 10/446 in intervention vs. 
control groups, respectively].
Observational studies
Fine et al. 1980 [55] Retrospective study. N = 100 
X-ray pelvimetry studies of 
cephalic presentations.
Compared the Thoms method of 
interpretation to the modified Ball 
technique for x-ray pelvimetry 
(comparing both to manual assessment 
of the pelvis) as prognostic indicators for 
safe vaginal delivery.
Uneventful nonoperative vaginal 
deliveries: 28.6% of patients with either 
inlet or midpelvic disproportion by the 
Thoms method, and in 22.5% of women 
with absolute disproportion in either 
plane by the modified Ball method.
Prediction of obstetric outcome: Neither 
technique significantly more accurate than 
manual assessment, or than the other.BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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presentations (N = 4 trials, N>1000 women). Pelvimetry
was associated with increased rates of Caesarean section
(OR = 2.17; 95% CI = 1.63–2.88) but had no impact on
PMR (4 RCTs; OR = 0.51, 95% CI = 0.18–1.42 [NS])
[LOE: 1+] (Additional file 7).
Conclusion
There is little support for the use of pelvimetry to predict
the need for Caesarean section in women with fetuses
with cephalic presentations, as the dynamic and individ-
ual nature of maternal tissue changes during labour and
fetal head moulding in the birth canal make antenatal pel-
vimetry a poor predictor of cephalopelvic disproportion.
The practice may result in inadvertent harm to the mother
by significantly increasing her risk of having a Caesarean
section, without increasing the benefit to fetus or neonate,
as pelvimetry shows no impact on stillbirth incidence.
However, deficiencies in the existing studies included in
Pattinson's meta-analysis should be noted: Parsons [57]
attributed the increased perinatal mortality and birth
asphyxia reported by Crichton [58] to lack of availability
of electronic fetal monitoring, not to cephalopelvic dis-
proportion. Even more problematic, the 2 deaths docu-
mented by Richards [59] occurred in utero prior to labour,
which imply that cephalopelvic disproportion was not
implicated. Treatment allocation strategies in all trials
were of poor quality.
Given the deficiencies in existing studies, it remains plau-
sible that other forms of imaging could effectively diag-
nose true cephalopelvic disproportion and avert stillbirth
via Caesarean section in these cases. We classified the
overall evidence as Grade C and found no evidence in
support of using pelvimetry for preventing stillbirths.
Detection and management of maternal diabetes mellitus
Background
In pregnant women, pre-existing diabetes mellitus can
cause severe complications for both mother and child
during pregnancy and delivery, including congenital mal-
formations, hypertension, pre-eclampsia, macrosomia
and intrauterine fetal death [60-63]. Macrosomia (large
size for gestational age) increases the risk to the fetus of
birth trauma, including shoulder dystocia, bone fractures
and brachial plexus injury, in addition to obstructed
labour. Good metabolic control in the mother from prior
to conception through the postpartum period reduces the
risk of these complications [64-66]. Because pre-gesta-
tional diabetes is a known risk factor for stillbirth, women
with this condition are usually offered intensive surveil-
lance and management during pregnancy, which may
include glycaemic control efforts through diet, exercise,
and/or insulin therapy with glucose monitoring, frequent
fetal surveillance using tests of fetal well-being, and/or
induction at or before term. Despite widespread practice
of this protocol, a recent UK study demonstrated a 4-fold
higher rate of stillbirth among women with pre-gesta-
tional diabetes compared to non-diabetic women, with
83% of stillbirths unrelated to congenital malformations
[60].
There is also substantial confusion surrounding optimal
screening for and management of glucose intolerance and
gestational diabetes. Gestational diabetes and impaired
glucose tolerance are relatively common and, like pre-ges-
tational diabetes, have been linked with adverse perinatal
outcomes including stillbirth and shoulder dystocia as a
consequence of fetal macrosomia [67,63,68]. However,
how to best screen for gestational diabetes is controver-
sial. The American Diabetes Association, the American
College of Obstetricians and Gynecologists, and the
World Health Organization recommend universal screen-
ing for gestational diabetes based on the conclusion that
selective screening is inadequate [69-72], while the US
Preventive Services Task Force concluded that there is
insufficient evidence of benefit to justify universal screen-
ing for gestational diabetes. As with management of pre-
gestational diabetes, intensive management of gestational
diabetes includes glucose monitoring, dietary regulation,
and tests of fetal well-being. The need for insulin therapy
is usually less for gestational diabetes than with pre-gesta-
tional diabetes.
Literature-based evidence
Our literature search identified 4 reviews and 12 other
intervention and observational studies reporting perinatal
outcomes after management of women with any form of
diabetes mellitus (Table 8).
Intensive management
Tuffnell et al. [73] undertook a systematic review of RCTs
(N = 3) of strategies for intensive management of women
with gestational diabetes and/or impaired glucose toler-
ance in pregnancy (N = 223), including obstetric monitor-
ing, dietary regulation, and insulin therapy in some cases.
No trials of treatments for gestational diabetes were
included, however, and of the trials of treatments for
impaired glucose tolerance that reported perinatal out-
comes, only 1 trial (N = 68) of mostly Hispanic patients
reported birth trauma incidence. This study found no sig-
nificant difference between the group receiving intensive
management versus any minimal treatment (RR = 0.37,
95% CI: 0.02–8.86 [NS]). Caesarean section rates were
not significantly different [LOE: 1+].
A number of studies compared different strategies of man-
agement of diabetic pregnant women, including glycae-
mic monitoring and control, diet and exercise regimens,
and insulin treatments. In a prospective population-based
study of intensive management of women with diabetesBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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Table 8: Impact of detection and management of maternal diabetes mellitus on stillbirth and perinatal mortality
Source Location and Type of Study Intervention Stillbirths/Perinatal 
Outcomes
Reviews and meta-analyses
Russell et al. 2007 [67] USA.
Review. 3 RCTs included, 1 
reported perinatal outcomes.
Assessed the impact of treatment 
of gestational diabetes on perinatal 
outcomes.
Serious perinatal complication 
(shoulder dystocia, nerve injury, 
fracture, or perinatal death): 67% 
reduction (1 RCT).
Macrosomia: 53% reduction (1 
RCT).
2 of 3 studies lacked power to 
detect a difference in perinatal 
outcomes.
Tuffnell et al. 2003 [73]. US, UK.
Review (Cochrane). 3 RCTs and 
quasi-RCTs included (N = 223 
pregnant women with impaired 
glucose tolerance)
Assessed the effect of treatments 
for impaired glucose tolerance on 
perinatal outcome.
PMR: Insufficient data to assess.
Reduction in BW > 90% 
percentile: RR = 0.55, 95% CI: 
0.19–1.61) [NS]
Boulvain et al. 2001 [84] USA.
Review (Cochrane). 1 RCT 
included (N = 200 term diabetic 
women).
Assessed the effects of a policy of 
elective delivery (intervention) vs. 
expectant management (controls) 
on maternal and perinatal 
mortality and morbidity.
PMR: RR not estimable
[0/100 in both groups].
Mukhopadhyay et al. [81] United Kingdom.
Review (non-Cochrane). 5 RCTs 
included (N = 182 diabetic 
pregnant women).
Compared the impact of 
continuous subcutaneous insulin 
infusion (CSII) (intervention) with 
multiple daily insulin injections 
(MDI)/intensive conventional 
therapy (ICT) (controls).
SBR: OR = 2.50 (95% CI: 0.53 – 
11.77) [NS]; P = 0.25
[6/94 (6.4%) vs. 1/88 (1.1%) in 
intervention and control groups, 
respectively].
Intervention studies
Hod et al. 2008 [82] Multicentre, multinational. 63 
study sites in 18 countries.
Open-label RCT. N = 322 
pregnant type I diabetic women (N 
= 157 intervention group, N = 165 
controls).
Assessed the impact of mealtime 
insulin Aspart (IAsp) (intervention) 
with human insulin (HI) (controls), 
both in combination with basal 
neutral protamine Hagedorn 
(NPH) insulin.
SBR: one in each group.
PMR: 14 vs. 22/1000 births in 
intervention and control groups, 
respectively.
Bancroft et al. 2000 [174] UK (West Yorkshire). Hospital-
based study (district general 
hospital and large teaching 
hospital).
RCT. Pregnant women (N = 68) 
with impaired glucose tolerance.
Compared the effects in a group 
that monitored plasma glucose up 
to 4× daily (intervention) vs. an 
unmonitored group (controls). 
Median plasma glucose 
measurements in intervention 
group = 118 (range: 0–500); 19% 
of women in the monitored group 
treated with insulin.
PMR: 0/36 vs. 0/32 in intervention 
vs. control groups, respectively 
[NS]
NMR: 0/36 vs. 0/32 in intervention 
vs. control groups, respectively 
[NS]
Karmon et al. 2009 [175] Israel.
Retrospective cohort study.
Measured pregnancy outcomes in 
women with diet-controlled 
gestational diabetes subject to a 
routine policy of labour induction 
at 40 weeks.
Rates of dystocia, congenital 
malformation, and macrosomia 
higher in offspring of diet-
controlled diabetic patients than 
non-diabetic patients.
Perinatal mortality: no difference 
when adjusted for confounders.
SBR: Higher in non-diabetic 
women after 40 weeks (likely due 
to policy of induction of diabetic 
women at 40 weeks).BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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Langer et al. 1994 [74] USA (Texas). Population-based.
Prospective study. Pregnant 
women (N = 2461; N = 1145 
intervention, N = 1316 diabetic 
controls) with gestational diabetes 
and a non-diabetic control group 
(N = 4922).
Compared the impact of 
intensified management 
(intervention) vs. conventional 
management (diabetic controls) vs. 
non-diabetic controls on adverse 
pregnancy outcomes.
SBR: 1/1000 (N = 1145) vs. 4/1000 
(N = 1316) vs. 4/1000 (N = 4922) 
in the intervention, diabetic 
controls and non-diabetic controls, 
respectively.
Macrosomia, Caesarean section, 
metabolic complications, shoulder 
dystocia, NICU days, and 
respiratory complications lower 
among intervention group than 
diabetic controls; comparable to 
non-diabetic controls.
Observational studies
Aucott et al. 1994 [83] USA.
Prospective study. Pregnant 
patients (N = 78) with pre-
gestational diabetes vs. matched 
non-diabetic pregnant controls (N 
= 78).
Compared the impact on stillbirth 
of treatment with insulin 
(exposed) by either infusion pump 
(N = 20) or split-dose therapy (N 
= 58) vs. matched controls 
(unexposed).
SB: 1/78 vs. 0/78 in exposed vs. 
unexposed groups, respectively.
Fadel et al. 1982 [176] USA.
Observational study. N = 84 
women with gestational diabetes, 
N = 23 women with pre-
gestational diabetes.
Compared the impact of a 
protocol of intensive diabetes 
management including frequent 
prenatal visits, strict metabolic 
control, antepartum monitoring 
including estriols and contraction 
stress tests, liberal hospitalization 
policy, fetal lung maturity 
assessment, and intrapartum fetal 
monitoring.
SB: 1 antepartum SB among 
women with gestational diabetes 
(due to true knot in cord); 0 SB in 
women with pre-gestational 
diabetes.
Caesarean section: 15.4% among 
gestational diabetics, 56.5% among 
pre-gestational diabetics.
Macrosomia: 20% among 
gestational diabetics, 13% among 
pre-gestational diabetics.
Banerjee et al. 2004 [77] India. Antenatal clinic.
Prospective study. N = 240 
women with gestational (GDM) 
and pre-gestational (PGDM) 
diabetes mellitus.
All women were placed on 
exercise, diet, and/or insulin 
therapy. And were divided into 
three groups based on blood 
glucose levels and HbA1C: Tight 
Glycaemic Control (TC), 
Acceptable glycaemic control (AC) 
and uncontrolled glycaemic group 
(UC).
PMR: 4.16% vs. 18.2% vs. 22.2% in 
the TC, AC and UC subgroups of 
GDM.
PMR: 0% vs. 20% vs. 40% in TC, 
AC and UC subgroups of PGDM.
Gonzalez-Quintero et al. 2007 
[76]
USA. Centralised perinatal 
database.
Retrospective study on 
prospective data. N = 3,218 
women participating in the 
outpatient GDM management 
programme.
Compared the impact on stillbirth 
of women whose blood glucose 
levels were controlled vs. those 
uncontrolled.
SBR (n,%): 2 (0.1) vs. 4 (0.3) in 
women with controlled vs. 
uncontrolled GDM.
Huddle et al 1993 [79] South Africa (Soweto).
Retrospective study. Patient 
records (N = 733 women; N = 
348 with gestational diabetes).
To assess the impact on perinatal 
mortality of the use of a specialised 
service for diabetic pregnant 
women (intervention) vs. non-use 
of the service (controls).
PMR: 3.7% vs. 15.6% in 
intervention vs. controls, 
respectively.
McElvy et al. 2000 [78] USA.
Retrospective before-after study. 
Pregnant Type-1 diabetic women 
enrolled peri-conceptionally (N = 
306; N = 111 before, N = 103 
during, N = 92 after programme).
To evaluate the impact on 
perinatal mortality of a focused 
preconceptional and early 
pregnancy programme for Type 1 
diabetes including strict glucose 
control and antepartum fetal 
surveillance from 32 weeks 
gestation until delivery.
PMR: 3% vs. 2% vs. 0% before, 
during, and after the programme, 
respectively.
Table 8: Impact of detection and management of maternal diabetes mellitus on stillbirth and perinatal mortality (Continued)BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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Landon et al. 1992 [80] USA (Ohio). 2 teaching hospitals.
Prospective cohort study. 
Pregnant women (N = 114) with 
insulin-dependent diabetes. Non-
stress testing was begun weekly at 
28–30 wks and 2× weekly at 32 
wks (N = 1676 NSTs performed 
(14.7+/-3.2 tests per patient)).
8% of tests (N = 134) non-
reactive, necessitating a biophysical 
profile.
To determine whether maternal 
vascular disease and/or glycaemic 
control are associated with fetal 
condition in diabetic pregnancies 
by comparing the effect of reactive 
(exposed) vs. non-reactive 
(unexposed) NST on perinatal 
outcomes.
Fetal death (miscarriage + SB): 1/
114.
N = 10 deliveries among patients 
with abnormal test results.
No significant differences in 
ambulatory glucose profile data in 
exposed vs. unexposed groups.
No significant differences in 
glycaemic parameters in women 
delivered for suspected fetal 
compromise vs. nonintervention 
group.
8/20 (40%) women with 
nephropathy or hypertension 
required delivery for fetal well-
being, vs. 2/94 women (2%) 
without nephropathy or 
hypertension but with abnormal 
test results (P < 0.001).
Nachum et al. 2001 [177] Israel.
Prospective controlled study. Pre-
gestationally and gestationally 
diabetic women (N = 681 women; 
N = 801 pregnancies) recruited 
1986–1989.
Compared the impact of diabetic 
pregnancies managed by 
hospitalisation vs. those managed 
by ambulatory care.
NMR: 1/394 vs. 0/407 in 
hospitalised vs. ambulatory care 
groups, respectively.
Table 8: Impact of detection and management of maternal diabetes mellitus on stillbirth and perinatal mortality (Continued)
mellitus (N = 1145), Langer et al [74] observed that an
intensively managed group of women with diabetes had
rates of stillbirth and neonatal complications similar to
non-diabetic controls (N = 4922), while diabetic women
given conventional management (N = 1316) had higher
rates of these adverse outcomes [LOE: 2+]. Crowther et al.
[75] randomly assigned women with gestational diabetes
to receive either dietary advice, blood glucose monitoring,
and insulin therapy as needed, or routine care, and
reported decreased perinatal mortality associated with the
intervention compared to the routine care group (0 versus
5 perinatal deaths in intervention versus routine care
groups, respectively, P = 0.07) [LOE: 1-] (Additional file
8).
In the US, Gonzalez-Quintero et al. [76] conducted an
observational study to assess the impact on perinatal out-
comes of glycaemic control among women with gesta-
tional diabetes attending an outpatient gestational
diabetes management programme. Over one-third of the
participants in the group with poor glycaemic control had
at least one of the factors in the composite study outcome
variable (macrosomia, large-for-gestational-age, hypogly-
caemia, jaundice, or stillbirth) compared with only 24%
in the well-controlled group (P < 0.001) [LOE: 2-]. A
somewhat less rigorous intervention study in India (N =
240 mothers) by Banerjee et al. [77] sought to assess the
incidence of fetal complications in both gestational and
pre-gestational diabetic pregnant women with tight versus
acceptable or uncontrolled glycaemic control. In women
with pre-gestational diabetes, the tight glycaemic control
group had the lowest perinatal mortality (4.16% versus
18.8% versus 22.2% in tight, acceptable, and uncon-
trolled glycaemic control groups, respectively). In women
with gestational diabetes, the same trend was noted with
even greater impact of tight glycaemic control (0% versus
20% versus 40% in tight, acceptable, and uncontrolled
glycaemic control groups, respectively). No statistical sig-
nificance measures were provided [LOE: 1-].
In the US, McElvy et al. [78] conducted an evaluation of a
programme that worked to achieve strict glycaemic con-
trol before and during early pregnancy in women with
pre-gestational diabetes (N = 306), with intensive
antepartum surveillance from 32 weeks gestation until
delivery. Perinatal mortality declined steadily from 3%
before the programme to a rate comparable to general
population levels after completion of the programme
[LOE: 1-]. In Soweto, South Africa, Huddle et al [79]
reported that a programme involving gestational diabetic
women given special services during pregnancy observed
lower rates of perinatal mortality among women partici-
pating in the service compared to non-users of the service
(3.7% versus 15.6%, respectively), but no statistical data
was furnished [LOE: 3].
A descriptive study by Landon et al. [80] of non-stress test-
ing (with delivery for non-reactive tests) in women with
pre-gestational diabetes found no differences in glycaemic
parameters in women delivered for suspected fetal com-
promise compared to a non- intervention group, suggest-BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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ing the possibility that glycaemic control was unrelated to
fetal compromise [LOE: 3].
Several studies assessed the impact on perinatal outcomes
of mode of insulin treatment. Mukhopadhyay et al. [81]
conducted a meta-analysis of RCTs (6 trials) comparing
the impact of continuous subcutaneous insulin infusion
versus multiple-dose insulin on glyacemic control and
pregnancy outcome in diabetic women. Neither glycae-
mic control nor pregnancy outcomes were different
between treatment groups [LOE: 1++] (Additional file 9).
In Israel, Hod et al. [82] conducted a small RCT (N = 322
women) comparing the impact on fetal and perinatal out-
comes of insulin aspart, a fast-acting insulin analogue,
versus human insulin therapy in women with pre-gesta-
tional diabetes. A slight trend toward lower perinatal mor-
tality was observed in the insulin aspart group compared
to the human insulin group (14/1000 versus 22/1000,
respectively), but no statistical significance data was
reported [LOE: 1-]. A study of insulin therapy using either
pump infusion or split-dose therapy found no difference
in rates of perinatal mortality in the treated groups com-
pared to non-diabetic controls [83].
Elective delivery
A Cochrane review by Boulvain et al. [84] assessed trials of
expectant management versus elective delivery in term
women with pre-existing diabetes mellitus; only 1 trial
was included (N = 200), which documented no perinatal
mortality in either group [LOE: 1+] (Additional file 10).
Conclusion
While data from RCTs is scarce, the limited evidence,
largely from clinical management of diabetic patients
(Grade C evidence), suggests that pregnant women who
do not have vascular complications and with good glycae-
mic control do not as a group have an increased risk of
stillbirth above the general population [85]. In settings
with poor access to care and high prevalence of gestational
diabetes, perinatal mortality has been shown to be
reduced with diabetes screening and treatment [79].
Although retrospective studies reveal declines in the inci-
dence of stillbirth among diabetic women in low-preva-
lence populations where diabetes care is available [86],
few prospective trials have been able to show any impact
on stillbirths or perinatal mortality, largely owing to the
high sample sizes required for such studies [63]. Adequate
glycaemic control and monitoring during pregnancy are a
reasonable means for reducing stillbirths that has been
shown to reduce many complications that may be related
to stillbirth, including congenital anomalies and macro-
somia. Where feasible, particularly in high-prevalence set-
tings, large studies with rigorous designs may help
confirm this recommendation.
Advanced monitoring in pregnancy
Antenatal fetal heart rate monitoring using 
cardiotocography
Background
Antenatal fetal surveillance studies are widely used to
assess fetal well-being and to identify the compromised
fetus. Fetal heart rate patterns are a principal component
of the majority of tests of fetal well-being, and cardioto-
cography, where it is available, is the method frequently
used to electronically record the fetal heart rate. In high-
income countries, beginning in the third trimester, cardi-
otocographic monitoring (electronic fetal monitoring)
has largely replaced intermittent auscultation (periodic
listening to the fetal heart rate using a stethoscope or
handheld Doppler device) for monitoring fetal heart rate.
During the antenatal period, external cardiotocography is
used, which employs a Doppler ultrasound transducer;
the mother's uterine contractions are also monitored
using a pressure transducer, with both transducers
strapped to the mother's abdomen while recording is in
process.
Antenatal fetal heart monitoring includes both non-stress
tests (NST) and contraction stress tests (CST). Fetal heart
rate patterns are classified as either reassuring (reactive),
non-reassuring (non-reactive) or abnormal, considering
heart rate baseline, variability, and decelerations. In high-
income countries, particularly the US, the NST is widely
accepted as a primary fetal surveillance tool in high-risk
pregnancies. It may be used in combination with ultra-
sound testing to observe fetal movement and amniotic
fluid indices. When an NST is non-reactive, its poor pre-
dictive value (< 50%) warrants confirmatory testing with
CST or a complete BPP [87]. During a CST, uterine con-
tractions are induced (usually with intravenous oxytocin,
but contractions can be generated using nipple stimula-
tion) and subsequent fetal heart accelerations and decel-
erations are monitored to detect possible cases of
uteroplacental insufficiency. It is important to note that
antenatal fetal heart monitoring is gestational-age
dependent; at 28 weeks' gestation, only about 60% of nor-
mally formed fetuses will have reactive non-stress testing
due to immaturity of the fetal autonomic nervous system
rather than placental insufficiency.
Variation between practitioners in interpretation of cardi-
otocographic tracings can potentially lead to inappropri-
ate intervention, or false reassurance without appropriate
intervention. Tracings are notoriously difficult to inter-
pret, as fetal sleep patterns, labour progress, external stim-
uli, and opiate administration to the mother can alter fetal
heart rate changes in the absence of fetal hypoxia or dis-
tress [2]. Additionally, as indications of fetal distress often
indicate early delivery, the gestational age threshold at
which antepartum testing is initiated will depend on anBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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institution's ability to care for very preterm neonates,
which, in general, is earlier in high-income settings than
in lower-resource settings [21].
Literature-based evidence
We identified 1 Cochrane review and 4 observational
studies testing the impact of antepartum cardiotocogra-
phy (including both NST and CST) on perinatal outcomes
(Table 9).
Several studies described how well NST and CST results
correlated with subsequent perinatal outcome. An RCT by
Flynn et al [88] identified a significant association of NST
tracings (N = 569 tracings, N = 300 patients) with still-
births, neonatal deaths, fetal growth restriction, complica-
tions of intrauterine hypoxia, and low Apgar scores [LOE:
1+]. An observational study of high-risk pregnant women
(N = 561) by Rayburn et al [89] assessed NST tracings
within 1 week of delivery along with subsequent perinatal
Table 9: Impact of antepartum cardiotocography on stillbirth and perinatal outcomes
Source Location and Type of Study Intervention Stillbirths/Perinatal Outcomes
Reviews and meta-analyses
Pattison and McCowan 1999 [91] UK, Australia.
Meta-analysis (Cochrane). 3 RCTs 
included (N = 1279).
Compared the impact of electronic 
fetal monitoring with an antenatal 
CTG (intervention) vs. a control 
group where the results of the CTG 
were withheld from the caregiver or 
no monitoring was done on perinatal 
morbidity and mortality and 
maternal morbidity.
PMR (excluding lethal 
abnormalities): OR = 2.65 (95% CI: 
0.99–7.12) [NS].
[12/651 vs. 4/628 in intervention and 
control groups, respectively].
Observational studies
Evertson et al. 1978 [90]U S A .
Case series. N = 746 pregnant 
women undergoing 1119 CSTs.
Assessed the incidence of fetal 
deaths within one week of a negative 
CST.
SBR: 7/680 patients (1%) within 1 
week of a negative CST.
Fetal death in most cases resulted 
from factors other then 
uteroplacental insufficiency 
(umbilical cord accident, 
malformations, and placental 
abruption)
Flynn et al. 1982 [88]U K .
RCT. Pregnant patients (N = 300) 
with non-stress antepartum 
cardiotocography tracings (N = 
569; N = 144 intervention, N = 156 
controls).
Compared impact on pregnancy 
outcomes of revealing 
cardiotocography results to clinician 
(intervention) vs. concealing results 
(controls).
SBR+NMR: Significant association 
with 'non-reactive' traces.
Significant association of nonreactive 
traces with rates of fetal growth 
restriction, admission to special care 
baby unit, Apgar scores at 1 and 5 
min.
Freeman et al. 1982 [92] USA and Canada. 18 institutions.
Comparison of diagnostic tests. 
Pregnant women (N = 6168; N = 
4626 CST, N = 1542 NST) with 
increased risk for uteroplacental 
insufficiency.
Compared the impact on fetal 
outcomes of CST (intervention) vs. 
NST (comparison) for primary fetal 
surveillance.
PMR: 8.4/1000 vs. 21.4/1000 in 
intervention vs. comparison groups, 
respectively (P < 0.05). After 
correction for congenital anomalies 
and unrelated causes: 3.5/1000 vs. 
7.1/1000 intervention vs. 
comparison groups, respectively (P 
< 0.05).
Fetal death (miscarriage+SB): 1.1/
1000 vs. 7.8/1000 in intervention vs. 
comparison groups, respectively (P 
< 0.05). After correction: 0.4/1000 
vs. 3.2/1000 in intervention vs. 
comparison groups, respectively (P 
< 0.05).
Rayburn et al. 1980 [89] USA (Lexington). University 
hospital.
Prospective cohort study. High-risk 
clinic patients (N = 561) who had 
undergone NST within one week 
prior to delivery.
Compared the association of 
reactive vs. non-reactive NSTs vs. no 
testing with fetal outcomes.
SB: 1/509 in reactive non-stress 
group (cord accident).
Corrected PMR: 1/509 vs. 2/22 vs. 
20/1000 in reactive, non-reactive 
and no testing groups, respectively 
(P < 0.05).
Fetal compromise: 4%, 36%, and 
13% in reactive, non-reactive and no 
testing groups, respectively (P < 
0.001)BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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outcome. Perinatal mortality in patients with reactive
NSTs was comparable to that of patients with no apparent
antepartum complications (1/509 versus 6/1408, respec-
tively), and significantly lower than among untested
patients or patients with nonreactive NSTs (20/1000 and
2/22, respectively, P < 0.05) [LOE: 2-]. Evertson et al [90]
assessed the rates of fetal death within 1 week of negative
CST results in a cohort of patients (N = 680), identifying
only 7 deaths, of which most were due to factors other
than placental insufficiency, suggesting that the test had
low rates of false negatives.
A review by Pattison and McCowan [91] included 4 stud-
ies (N = 1,588 pregnancies) of the impact of cardiotocog-
raphy use on perinatal mortality in high or intermediate
risk pregnancies (Additional file 11). The trial reported a
trend toward increased perinatal mortality in the cardioto-
cography group versus controls receiving no monitoring
or whose cardiotocography results were concealed from
the clinician; (3 trials, N = 1279 pregnancies, OR = 2.85,
95% CI: 0.99–7.12). Four of the 7 deaths in the largest
trial reporting perinatal deaths were associated with fetal
infection and prematurity, suggesting these deaths were 
not associated with the intervention. There was no
increase in the incidence of elective Caesarean section or
induction of labour [LOE: 1++].
Freeman et al [92] compared results from the NST (N =
1542 women) to the CST (N = 4626) for primary fetal sur-
veillance and found a nearly 8-fold higher risk of antepar-
tum fetal death in the NST group (7.8/1000 versus 1.1/
1000, respectively, P < 0.05). Corrected for congenital
anomalies and unrelated causes, the differential in
antepartum fetal death remained 8-fold higher in the NST
group (3.2/1000 versus 0.4/1000, respectively, P < 0.05)
[LOE: 2+].
Conclusion
There are relatively few RCTs of antepartum fetal heart rate
surveillance (Grade C evidence), though observational
studies clearly indicate a correlation between non-reassur-
ing cardiotocographic traces and adverse perinatal out-
comes, including stillbirth. Although there is a Cochrane
review on antepartum cardiotocography [91] showing a
trend toward increased risk of perinatal mortality, the
study was underpowered to detect such an impact, and the
causes of the deaths observed appeared unlikely to have
been preventable. While RCTs are lacking to evaluate an
impact of NSTs in reducing stillbirth, apparent reductions
in stillbirth rates have followed the incorporation of the
NST into protocols for management of high-risk preg-
nancy in the United States [21]. As with fetal movement
monitoring and umbilical Doppler velocimetry, the rate
of false-positives with a non-reactive NST is high enough
that additional testing, whether CST or BPP, is advised to
guard against unnecessary intervention.
When used experimentally as a primary fetal surveillance
tool, CST use was associated with lower rates of antepar-
tum stillbirth [92], suggesting that it could be useful for
primary fetal surveillance testing in pregnancies at highest
risk of stillbirth, including those of women with hyperten-
sion, diabetes, and intrauterine growth restriction. As it
typically uses intravenous oxytocin to stimulate uterine
contractions, the CST is more technologically intensive
than the NST and can induce labour; thus, it is contraindi-
cated for patients with placenta previa, placental abrup-
tion, previous classical Caesarean section, and premature
rupture of membranes [87]. The CST should be conducted
cautiously in cases of multiple pregnancy, incompetent
cervix, and polyhydramnios.
Fetal biophysical profile (BPP) test scoring for assessing 
high-risk pregnancy
Background
The BPP was conceptually derived from the Apgar score
that is used to rate the condition of the newborn [93].
Using NST monitoring with cardiotocography and fetal
ultrasound, the BPP collects 5 indicators of fetal well-
being: fetal heart rate reactivity, breathing movements,
gross body movements, muscular tone and qualitative
amniotic fluid volume. Indications of fetal compromise
often suggest the need for early delivery by induction of
labour or Caesarean section.
Literature-based evidence
We identified one Cochrane review and four other obser-
vational studies of BPP reporting perinatal mortality out-
comes (Table 10). A multi-institutional study in the US by
Freeman et al [94] compared antepartum BPP versus NST,
and reported that the fetal death rate among false nega-
tives was several times lower among fetuses tested with
BPP compared to the NST, though rates of false positive
results with BPP were higher than with NST. Several other
observational clinical studies were identified but had
insufficient rigor or size to contribute meaningfully to the
evidence base associating BPP results with stillbirth inci-
dence [95-97].
Lalor et al. [1] undertook a Cochrane review of RCTs of
variable quality (5 trials, N = 2839 women) comparing
BPP with other forms of fetal assessment in women with
high risk pregnancies (Additional file 12). There were no
significant differences among pregnancies evaluated by by
the various methods of fetal assessment in perinatal mor-
tality (RR = 1.33, 95% CI: 0.60–2.98) or Apgar score <7 at
5 minutes (RR = 1.27, 95% CI: 0.85–1.92) [LOE: 1+].BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
Page 23 of 48
(page number not for citation purposes)
Conclusion
Compared with conventional fetal monitoring, which is
based primarily on cardiotocography/NST, BPP appears
to offer no improvement in pregnancy outcomes (Grade
C evidence). Although rates of false negative test results of
the BPP are low, rates of false positives are high. The total
number of subjects included in the meta-analysis remains
small (N = 2974), and some of the studies carry a high risk
of allocation bias. Although there is no consensus on opti-
mal protocol for fetal monitoring, studies demonstrate
that it is reasonable to implement the modified BPP
(which consists of an NST and amniotic fluid volume
measurement only), with full BPP or other tests such as
the CST reserved for abnormal test results [98]. This pas-
sive and rapid approach to monitoring has been shown to
be more cost-effective without diminishing its predictive
value [99]. For reasons of cost and simplicity, the modi-
fied BPP may also prove to be more implementable than
Table 10: Impact of fetal BPP scoring on stillbirth and perinatal outcomes
Source Location and Type of Study Intervention Stillbirths/Perinatal 
Outcomes
Reviews and meta-analyses
Lalor et al. 2008 [1] USA, UK.
Meta-analysis (Cochrane). 4 RCTs 
included (N = 2839 pregnant women).
Compared the effects of complex (BPP; 
intervention) vs. simple fetal monitoring 
(cardiotocography and maximum pool 
depth) (controls).
PMR (including major 
malformations): RR = 1.33 (95% 
CI: 0.60–2.98) [NS]
[13/1405 vs. 10/1434 in 
intervention vs. control groups, 
respectively].
PMR: RR = 1.30 (95% CI: 0.58–
2.92) [NS]
[13/1405 vs. 11/1434 in 
intervention vs. control groups, 
respectively].
Observational studies
Awad 1991 [101] Egypt. Al Fayrouz Hospital.
Before-after study. N = 319 women (N 
= 160 intervention, N = 159 controls). 
Routine BPP introduced in 1990; 
compared to historical controls without 
BPP at same hospital prior to 1990.
Assessed the impact on perinatal 
mortality of introduction of routine BPP 
(intervention) vs. historical controls.
SBR: 0/1000 vs. 6/29/1000 in 
intervention vs. control groups, 
respectively.
PMR (excluding malformations 
and alloimmunization disorders): 
6.25/1000 vs. 25.16/1000 in 
intervention vs. control groups, 
respectively.
Golde et al. 1984 [97] USA. University of Southern California 
Medical Centre and Women's Hospital, 
Los Angeles,
Case series. Pregnant diabetic women 
(N = 107) vs. historic controls (N = 
140) undergoing antepartum fetal 
surveillance.
Compared the impact of a package of 
nonstress heart rate testing, backed up 
by either fetal BPP or CST twice weekly 
(intervention), vs. weekly NSTs and daily 
plasma estriols (controls).
SB: 3/107 vs. 1/140 in intervention 
vs. control groups, respectively. 0 
unexplained losses in either 
group.
de la Vega A 2002 [95] Puerto Rico. Private clinic.
Case series. Pregnancies (N = 1810) 
≥20 wks gestation. High-resolution 
sonograph was performed in each 
trimester; BPP in 3rd trimester if risk 
factor was identified.
To assess the impact of testing fetal well-
being using sonography and BPP in clinic 
cases (intervention) compared with the 
US average.
SBR: 14/1810 (7.7/1000 births) in 
this series vs. the U.S. national 
average of 6.7–7.8/1000 births.
Kennelly et al. 2007 [96] UK. Single tertiary centre.
Retrospective study. Records from Fetal 
Medicine Database, 2000–2005. 
Pregnant women (N = 39) with SGA 
twins (19 monochorionic sets, 13 
dichorionic sets) with absent or 
reversed end diastolic flow in the 
umbilical artery.
To assess the impact of active 
monitoring with daily BPP after 
estimated fetal weight ≥500 g in both 
twins and gestational age ≥24 wks. 
Delivery was timed based on abnormal 
BPP, two equivocal BPP within 12 h or 
gestational age ≥32 wks.
Fetal death (miscarriage+SB): 
None.BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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the full BPP in low-/middle-income country contexts with
ultrasound and cardiotocographic capacity [100,101].
Vibroacoustic stimulation
Background
Adjunctive vibroacoustic stimulation with the NST is used
less often than CST or BPP after non-reassuring NST
results. Vibroacoustic stimulation provokes fetal response
using a sound-emitting device placed on the maternal
abdomen near the fetal head, along with simultaneous
cardiotocography to document fetal movements and
heart traces. Theoretically, the resultant startle reflex in the
fetus and subsequent fetal heart rate acceleration or tran-
sient tachycardia following vibroacoustic stimulation pro-
vide reassurance of fetal well-being and minimise
unnecessary intervention for nonreactive tests [102].
Literature-based evidence
Our literature search identified one Cochrane review on
vibroacoustic stimulation and four other observational/
interventional studies (Table 11). In a Cochrane review of
vibroacoustic stimulation in conjunction with tests of
fetal well-being (9 RCTs, N = 4838 women), Tan et al.
[102] found that fetal vibroacoustic stimulation reduced
the incidence of non-reactive antenatal cardiotocography
tests (7 trials; RR = 0.62, 95% CI: 0.52–0.74) but the study
was underpowered to detect impact on perinatal mortality
of vibroacoustic stimulation compared to no or mock
stimulation (RR = 0.32, 95% CI: 0.01–7.78 [NS]) [LOE:
1+] (Additional file 13).
In Greece, Papadopoulos et al. [103] found no difference
in fetal deaths in a group of women (N = 2833) ran-
domised to vibroacoustic stimulation or no stimulation
(10 [0.74%] versus 9 [0.6%], respectively [NS]). In India,
Sood [104] conducted an RCT comparing vibroacoustic to
mock stimulation and found no statistically significant
difference in PMR (1.8% versus 2.9%, respectively; OR =
0.62, 95% CI: 0.05–5.57, P = 0.67).
New meta-analysis
We conducted a meta-analysis using available RCTs com-
paring outcomes (intrauterine or perinatal deaths) of
pregnancies monitored by vibroacoustic stimulation com-
pared to mock or no stimulation (4 trials, N = 1935
women in the vibroacoustic group, N = 2052 women in
the mock or no stimulation group) (Figures 2 and 3).
Three trials reported perinatal deaths and 1 reported intra-
uterine deaths, so the outcome of the meta-analysis was
expanded and renamed as 'intrauterine or perinatal
deaths' to include all 4 of the studies. We found no impact
of vibroacoustic stimulation on intrauterine or perinatal
deaths (RR [Fixed] = 0.98, 95% CI: 0.46–2.10 [NS]; RR
[Random] = 0.99, 95% CI: 0.46–2.16 [NS]).
Conclusion
The benefits of using fetal vibroacoustic stimulation
adjunctively with NSTs must be weighed with respect to
the effect on the predictive reliability of the tests and the
safety of the procedure. Vibroacoustic stimulation appears
to offer maternal, fetal, and clinical benefits by decreasing
the incidence of non-reactive cardiotocography and
reducing the testing time. Although there are several RCTs
and a Cochrane review evaluating vibroacoustic stimula-
tion during pregnancy (Grade B evidence), the non-signif-
icant impact on perinatal mortality does not support
including this intervention presently. Further RCTs are
needed to determine optimal intensity, frequency, dura-
tion and position of vibroacoustic stimulation, as well as
efficacy, predictive reliability, safety (in terms of fetal
hearing impairment and neurological development) and
perinatal outcome.
Amniotic fluid volume assessment
Background
Amniotic fluid protects and supports the fetus during
pregnancy. Both low amniotic fluid (oligohydramnios)
and high amniotic fluid (polyhydramnios) are abnormal
and potentially place the fetus at risk of adverse outcomes.
Oligohydramnios can be associated with maternal condi-
tions including pre-eclampsia, or with placental mem-
brane rupture, fetal growth restriction, post-term
pregnancy, fetal kidney problems, or fetal or placental
abnormalities [105,106]. Polyhydramnios is frequently
associated with maternal diabetes mellitus, maternal car-
diac problems, twin-twin transfusion syndrome, or fetal
or placental malformations, but in 50–60% of cases, it is
idiopathic [107-110]. Until ultrasound became available,
the invasive nature of amniotic fluid testing limited its
clinical usefulness [111]. Using ultrasound, multiple
methods for measuring amniotic fluid have been devel-
oped and are used to identify at-risk pregnancies. The
amniotic fluid index (AFI) is a measure of the amount of
amniotic fluid which is calculated by summing centime-
ters of depth of 4 different pockets of fluid; alternatively,
the single deepest vertical pocket or maximum pool depth
may be used. At term, many clinicians will induce labour
or perform Caesarean section after diagnosis of decreased
amniotic fluid volume to prevent an adverse pregnancy
outcome. However, using assessments of amniotic fluid
volume to predict fetal complications is controversial, and
the utility of amniotic fluid assessment is different when
used prior to versus after the onset of labour. Here, we
examine the potential for assessment of amniotic fluid
volume, or interventions to achieve normal amniotic fluid
volume, to effectively detect high-risk pregnancy or fetal
distress and subsequent adverse perinatal outcomes. We
also examined the impact of interventions to achieve nor-
mal amniotic fluid volume on perinatal outcomesBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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Literature-based evidence
Our literature search identified two Cochrane reviews,
one other review, and 15 other interventional or observa-
tional trials of amniotic fluid assessment to identify poly-
hydramnios or oligohydramnios that reported perinatal
outcomes (Table 12 and Table 13).
Polyhydramnios
Several observational studies explored the association of
polyhydramnios with perinatal mortality, with inconsist-
ent findings. Several observational studies [112] observed
that polyhydroamnios was an independent risk factor for
both perinatal mortality and intrapartum morbidity
[LOE: 2-]. A retrospective cohort study by Dashe et al.
[113] documented a fetal death rate of 4% in pregnancies
with polyhydramnios diagnosed by AFI, of which 40%
were unrelated to fetal malformations [LOE: 2-]. Magann
et al. conducted a review of idiopathic polyhydramnios
[107] including 4 studies that evaluated perinatal mortal-
ity with polyhydramnios after correcting for congenital
anomalies. In the larger studies, idiopathic polyhyram-
nios was associated with macrosomia and a statistically
significant 2- to 5-fold increase in the risk of perinatal
mortality [LOE: 2+] (Additional file 14). A retrospective
Table 11: Impact of vibroacoustic stimulation on stillbirth and perinatal outcomes
Source Location and Type of Study Intervention Stillbirths/Perinatal Outcomes
Reviews and meta-analyses
Tan et al. 2001 [102] Australia, USA, Mexico, Greece, 
Turkey, Thailand.
Meta-analysis (Cochrane). 8 RCTs 
included (N = 4838 women).
Compared the impact of fetal 
vibratory acoustic stimulation 
(intervention) vs. mock or no 
stimulation (controls).
Non-reactive antenatal 
cardiotocography test (7 RCTs): 
RR = 0.62 (95% CI: 0.52–0.74)
[176/2244 vs. 286/2239 in 
intervention vs. control groups, 
respectively.]
PMR (2 RCTs): RR = 0.32 (95% CI: 
0.01–7.78) [NS]
[0/476 vs. 1/464 in intervention vs. 
control groups, respectively].
Intervention studies
Papadopoulos et al. 2007 [103] Greece.
RCT. Pregnant women (N = 2833).
Compared the effect of vibroacoustic 
stimulation with a 3-s stimulus with 
an artificial larynx (repeated if BPP 
remained abnormal for 30 min; 
intervention) vs. no stimulation 
(controls).
Fetal death (miscarriage+SB): 10/
1349 (0.74%) vs. 9/1484 (0.6%) in 
intervention vs. control groups, 
respectively [NS]
Petrovic 1998. [178] Croatia.
RCT. Singleton pregnancies (N = 
494; N = 168 intervention, N = 326 
controls).
Groups were monitored using the 
modified BPP; given vibroacoustic 
stimulation in absence of fetal 
activity at the start of the BPP.
Compared the impact of 
vibroacoustic stimulation 
(intervention) vs. no stimulation 
(controls).
SBR: 2/168 vs. 4/326 in 
intervention vs. control groups, 
respectively.
Sood 2007 [104] India.
RCT. Singleton high-risk 
pregnancies (N = 214).
Compared the effect of vibroacoustic 
stimulation (intervention) vs. mock 
stimulation (controls). Both arms also 
had modified BPP conducted.
PMR: OR = 0.62 (95% CI: 0.05–
5.57) [NS]
[2/110 (1.8%) vs. 3/104 (2.9%) in 
intervention vs. control groups, 
respectively.
Observational studies
Salamalekis et al. 1994 [179] Greece.
Case series. High-risk pregnancies 
(N = 180).
Compared the association with fetal 
deaths of reactive (study group) vs. 
non reactive (controls) NST results 
for tests conducted 24 hrs before 
delivery.
Fetal death (miscarriage+SB): 1 
(0.67%) vs. 2 (6.25%) in 
intervention vs. control groups, 
respectively.BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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logistic regression analysis of SGA and appropriate-weight
fetuses with and without polyhydramnios determined
that the combination of SGA and polyhydramnios was an
independent risk factor for perinatal mortality compared
to normal weight-for-age infants with normal AFI values
(OR = 20.55; CI: 12.6–33.4) [114]. The association may
not apply to certain subsets of high-risk pregnancies, as a
similar study among women with gestational diabetes
who had AFI performed antenatally found no elevated
risk of perinatal morbidity or mortality among pregnan-
cies complicated by polyhydramnios compared to gesta-
tional diabetics without polyhydramnios [LOE: 2-]. No
intervention studies subsequent to diagnosis of polyhy-
dramnios were identified.
Oligohydramnios
Observational studies of oligohydramnios cases demon-
strated a consistent elevated risk of poor perinatal out-
comes. Anandakumar et al. [115] studied how AFI used
with non-stress cardiotocography and fetal acoustic stim-
ulation for non-reactive NSTs might predict adverse preg-
nancy outcome in high-risk pregnancies (N = 565
women). Of the 4 perinatal deaths in the group with low
AFI, 3 had had a reactive NST within 7 days of fetal death
[LOE: 2-]. In Italy, Locatelli et al. [116] reported rates of
oligohydramnios twice as high in pregnancies with poor
perinatal outcome than pregnancies with no adverse out-
come  [LOE: 2-]. However, oligohydramnios identified
during the intrapartum period did not appear associated
with adverse perinatal outcome in high-risk pregnancies:
Baron et al [117] observed that women with low AFI were
Meta-analysis (Forest plot, Fixed effects model) of impact of vibroacoustic stimulation versus mock or no stimulation on intra- uterine or perinatal deaths Figure 2
Meta-analysis (Forest plot, Fixed effects model) of impact of vibroacoustic stimulation versus mock or no stim-
ulation on intrauterine or perinatal deaths.
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Meta-analysis (Forest plot, Random effects model) of impact of vibroacoustic stimulation versus mock or no 
stimulation on intrauterine or perinatal deaths.
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more likely to have Caesarean section for fetal distress
than women with normal AFI, but the rates of neonatal
complications were similar [LOE: 2+].
One study found that in addition to the absolute volume
of AFI, the distribution of amniotic fluid by intrauterine
quadrants is predictive of fetal outcome. Myles et al. [118]
observed higher rates of meconium staining, poor 1-
minute Apgar scores, fetal heart decelerations, and fetal
acidaemia in pregnancies where fluid volume was higher
in the upper quadrants than in pregnancies where fluid
volume was higher in lower quadrants [LOE: 2+].
A number of observational studies, RCTs and a systematic
review compared AFI measurement to other methods of
measuring amniotic fluid in ability to predict poor perina-
tal outcome. In an observational study in Egypt, Youssef
et al. [119] (N = 174 women) found that the AFI was more
sensitive than the single largest vertical pocket measure-
ment in predicting perinatal mortality and multiple meas-
ures of perinatal morbidity. Morris et al. [120]
documented similar findings, but the sensitivity of AFI <
5 cm for major adverse fetal outcome was only 28 percent.
A Cochrane review [121] compared the evidence for the
predictive value of 2 methods of amniotic fluid assess-
ment (AFI versus single deepest vertical pocket) on
adverse pregnancy outcomes (Additional file 15). Com-
piling the evidence from available RCTs (4 trials, N = 3125
women), the authors found that AFI versus single deepest
vertical pocket led to significantly more cases of oligohy-
dramnios being diagnosed (RR [Random] = 2.33, 95% CI:
1.67–3.24), more frequent labour induction (RR [Fixed] =
2.10, 95% CI: 1.60–2.76) and higher rates of Caesarean
delivery for fetal distress (RR [Fixed] = 1.45, 95% CI:
1.07–1.97). They recommended that the single deepest
vertical pocket measurement be used because AFI resulted
in increased diagnoses of oligohydramnios and rates of
labour induction with no improvement in perinatal out-
comes compared to single deepest vertical pocket, suggest-
ing better predictive value of single deepest vertical
Table 12: Impact of amniotic fluid assessment for polyhydramnios on stillbirth and perinatal mortality
Source Location and Type of Study Intervention Stillbirths/Perinatal 
Outcomes
Reviews and meta-analyses
Magann et al. 2007 [107] USA, China
Systematic review. 7 studies included. N = 3 
studies of idiopathic polyhydramnios, N = 4 
studies of polyhydramnios that adjusted for 
congenital anomalies.
Assessed the association of idiopathic 
polyhydramnios on perinatal 
outcomes.
PMR: 2-fold to 5-fold increase in 
risk in polyhydramnios vs. normal 
AFI groups, respectively.
Observational studies
Mazor et al. 1996 [112] Israel.
Cohort study. Singleton pregnancies (N = 
4211) with intact membranes and pre-term 
delivery (< 37 wks).
Compared the effect in the group 
with increased amniotic fluid volume 
(exposed) vs. normal amniotic fluid 
volume (unexposed) by sonographic 
assessment.
PMR: OR = 5.8 (95% CI: 3.68–
9.11).
Intrapartum morbidity: OR = 2.8 
(95% CI: 1.94–4.03).
Polyhydramnios was an 
independent predictor of 
perinatal mortality and 
intrapartum morbidity.
Dashe et al. 2002 [113] USA.
Retrospective cohort study. N = 672 
singleton pregnancies with hydramnios 
categorised as mild, moderate, or severe 
based on greatest amniotic fluid index of 
25.0–29.9 cm, 30.0–34.9 cm, or 35.0 cm or 
more, respectively.
To characterise the prevalence and 
ultrasound detection of fetal 
anomalies in pregnancies with 
hydramnios, and to estimate anomaly 
and aneuploidy risks when no 
sonographic abnormality is noted.
77 (11%) of neonates had one or 
more anomalies.
Fetal death rate: 4%; 60% of 
these had anomalies.
Erez et al. 2005 [114] Israel.
Retrospective logistic regression analysis. N 
= 192 SGA neonates with polyhydramnios, 
N = 5,515 SGA neonates with normal 
amniotic fluid, N = 3,714 appropriate for 
gestational age (AGA) neonates with 
polyhydramnios, N = 83,763 AGA.
Assessed the impact of combined 
SGA and polyhydramnios on 
perinatal mortality.
PMR: OR = 20.55 (95% CI: 12.6–
33.4) comparing 
SGA+polyhydramnios to AGA 
fetuses with normal AFIBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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pocket. However, others have expressed concern that
inter-observer reliability is lower with single deepest verti-
cal pocket measurement (kappa = 0.33) compared to AFI
(kappa = 0.72) [122]. An RCT by Alfirevic et al [123] ran-
domised women to fetal monitoring by either AFI with
computerised cardiotocography, or maximum pool depth
determined by computerised cardiotocography, but
found no statistically significant difference in perinatal
outcome in the 2 groups. Another RCT by Oral et al [124]
(N = 101 pregnancies) compared fetal monitoring (with
cardiotocography) by either AFI or maximal vertical
pocket. Measurement of maximal amniotic fluid vertical
pocket proved slightly better than AFI in identifying post-
term pregnancies with abnormal perinatal outcomes.
Only one intervention RCT compared AFI to no amniotic
fluid assessment. Comparing AFI on admission (interven-
tion) to no AFI (controls), Chauhan et al [125] found that
women in the intervention group with a diagnosis of low
AFI (measured as ≤ 5 cm or ≤ 5th percentile) were no more
likely to have Caesarean section for fetal distress, neonatal
acidosis, or Apgar score < 7 at 5 minutes than untested
controls or women with normal AFI results; no perinatal
mortality statistics were reported [LOE: 1+].
One intervention strategy to improve perinatal outcomes
is to augment amniotic fluid volume in cases of oligohy-
droamnios. Hofmeyr and Gülmezoglu [126] undertook a
systematic review of RCTs (2 trials, N = 78 women) assess-
ing the impact of maternal hydration status (requesting
that women drink 2 litres of water prior to a repeat ultra-
sound) on AFI (Additional file 16). In women with and
without oligohydramnios, drinking water was associated
with an increase in amniotic volume (WMD for women
with oligohydramnios = 2.01, 95% CI: 1.43–2.60; WMD
for women with normal AFI = 4.5, 95% CI: 2.92–6.08).
Intravenous hypotonic hydration in women with oligohy-
dramnios was associated with an increase in amniotic
fluid volume (WMD = 2.3, 95% CI: 1.36–3.24), but isot-
onic intravenous hydration had no measurable effect.
Conclusion
Polyhydramnios is a clear risk factor for perinatal mortal-
ity, whether associated with congenital malformations,
placental insufficiency, or of idiopathic origin. However,
no studies reported the impact of interventions subse-
quent to a diagnosis of polyhydramnios after amniotic
fluid assessment, so the impact on stillbirth of amniotic
fluid screening for polyhydramnios remains unclear.
Although robust RCTs are limited, very low AFI values
(oligohydramnios) are frequently associated with poor
pregnancy outcomes, and in these cases a reactive NST
loses its usual reassuring value (Grade C evidence). Where
feasible, amniotic fluid volume estimation may be helpful
for identifying severe oligohydramnios, but further
research is needed to document subsequent intervention
and perinatal mortality outcomes to determine the cost-
benefit ratio of utilizing amniotic fluid assessment proce-
dures. Amniotic fluid assessment is complicated by high
variability of sequential measurements and use of differ-
ent measurement methods, which can compromise the
accuracy of the test. No particular method of amniotic
fluid volume assessment appears superior to another
[123,124], though using maximum vertical pool depth
rather than AFI appears to limit unnecessary inductions of
labour and Caesarean section by reducing diagnoses of
oligohydramnios. There is a need for further research to
test the impact of interventions to prevent or treat oligo-
hydroamnios, particularly in the antepartum period with
intact membranes, on perinatal outcomes.
Home versus hospital bed rest and monitoring for high-risk 
pregnancies
Background
Women with high-risk pregnancies, especially multiple
pregnancies and pregnancies complicated by hypertensive
disorders, are frequently admitted to hospital for bed rest
and monitoring. However, in some instances, more lim-
ited monitoring in facilities and home-based bed rest or
reduced physical activity may be as effective as hospital-
based monitoring. Home-based activity modification,
accompanied by outpatient surveillance and hospital
admissions only for complications, would offer cost sav-
ings over hospital admission, reduced burden on hospital
resources and personnel, and reduced disruption to the
life of the mother posed by lengthy hospital stays.
Literature-based evidence
The literature search identified two Cochrane reviews and
two other interventional studies comparing home-based
versus hospital-based methods of care for high-risk preg-
nancies (Table 14). The first Cochrane review [127]
assessed the effectiveness, in management of multiple ges-
tations, of hospital-based bed rest versus home bed rest
(reduced physical activity) with admission only for com-
plications (6 RCTs, N>600 women, N>1400 infants)
(Additional file 17). Hospital bed rest had no advantage
compared to domiciliary bed rest in reducing perinatal
mortality (OR = 0.89, 95% CI: 0.43–1.85), but birth
weights were slightly higher in the hospitalised group. In
the subset of trials of uncomplicated twin [128] and tri-
plet [129] pregnancies, there was no advantage of hospi-
tal-based bed rest compared to non-hospitalised patients
in preventing stillbirths (OR = 0.82, 95% CI: 0.38–1.77;
and OR = 6.69, 95% CI: 0.13–338.79; for twin and triplet
pregnancies, respectively) [LOE: 1++].
Another Cochrane review [130] evaluated the impact of
different degrees of bed rest compared with routine activ-
ity, as well as the effects of hospital-based versus home-BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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Table 13: Impact of amniotic fluid volume assessment for oligohydramnios and associated interventions on stillbirth and perinatal 
outcomes
Source Location and Type of Study Intervention Stillbirths/Perinatal Outcomes
Reviews and meta-analyses
Hofmeyr et al. 2002 [126] Japan, USA.
Review (Cochrane). 2 studies 
included (N = 78 women).
Assessed the impact of improved 
maternal hydration (drinking 2 litres 
water or intravenous fluids) on 
amniotic fluid volume and 
subsequent perinatal outcomes in 
women with oligohydramnios and 
normal amniotic fluid volume.
Increased amniotic fluid volume 
after hydration (women with 
oligohydramnios): weighted mean 
difference (WMD) = 2.01 (95% CI: 
1.43–2.60)
Increased amniotic fluid volume 
after hydration (women with normal 
amniotic fluid volume): WMD = 4.5 
(95% CI: 2.92–6.08)
IV hypotonic hydration (women 
with olighydramnios):
increased amniotic fluid 
volume=WMD 2.3 (95% CI: 1.36–
3.24)
Isotonic intravenous hydration: [NS]
Nabhan et al. 2008 [121] UK, USA.
Review (Cochrane). 4 RCTs 
included (N = 3125 women).
Compared the predictive value of 
AFI (intervention) versus single-
deepest vertical pocket 
(comparison) methods of amniotic 
fluid volume assessment in 
anticipating adverse perinatal 
outcomes.
Fetal acidaemia: [NS]
Presence of meconium: [NS]
Apgar < 7 at 5 min: [NS]
Caesarean section: [NS]
Diagnosis of oligohydramnios: 
RR[Random] = 2.33 (95% CI: 1.67–
3.24)
Induction of labour: RR[Fixed] = 
2.10 (95% CI: 1.60–2.76)
Caesarean for fetal distress: 
RR[Fixed] = 1.45 (95% CI: 1.07–
1.97)
Intervention studies
Alfirevic et al. 1997 [123] UK. Liverpool Women's Hospital.
RCT. Singleton, uncomplicated 
pregnancies (N = 500) with 
gestational age ≥ 290 days.
Compared the impact of fetal 
monitoring by either AFI and 
computerised cardiotocography 
(intervention), or maximum pool 
depth and computerised 
cardiotocography (controls).
PMR: 0/250 in both groups [NS]
Chauhan et al. 1995 [125] USA.
RCT. Pregnant women 26–42 wks' 
gestation in early labour.
Compared impact on perinatal 
outcomes of AFI on admission 
during early labour (intervention) 
vs. no AFI (controls).
Caesarean section for fetal distress: 
RR = 1.3 (95% CI: 1.1–1.7, P = 0.02).
[29/447 vs. 14/436 in intervention 
vs. control groups, respectively.]
LBW, macrosomia, Apgar <7, and 
admissions to the neonatal intensive 
care unit: [NS].
Oral et al. 1999 [124] Turkey.
RCT. Singleton, uncomplicated 
pregnancies (N = 101) of gestational 
age ≥ 290 days.
Compared the impact of either AFI 
and computerised cardiotocography 
(intervention) vs. maximal vertical 
pocket and computerised 
cardiotocography (controls). 
Electronic fetal heart monitoring 
was performed in all patients.
PMR: Maximal amniotic fluid vertical 
pocket appeared to be slightly 
better than AFI for identifying the 
post-term pregnancy at risk for 
abnormal perinatal outcome.BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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Observational studies
Anandakumar et al. 1993 [115] Singapore. National University 
Hospital.
Prospective cohort study. High-risk 
pregnant women (N = 565).
To evaluate the role of the AFI, 
used along with NST and fetal 
acoustic stimulation test, when 
required, in prediction of adverse 
pregnancy outcome.
PMR: 6/25, 4 in very low AFI (<5 
cm) group (3/4 had reactive NST <7 
days before death, P < 0.001 after 
controlling for NST results).
Baron et al. 1995 [117] USA.
Prospective cohort study. Pregnant 
women > 26 wks gestation who had 
an intrapartum AFI measurement.
Compared rates of adverse fetal 
and neonatal outcomes in women 
diagnosed with oligohydramnios via 
AFI (cases) vs. women with normal 
AFI (controls).
Meconium staining: RR = 0.67 (95% 
CI: 0.49–0.92) in cases vs. controls, 
respectively.
Variable decelerations: RR = 1.44 
(95% CI: 1.12–1.87) in cases vs. 
controls, respectively.
C-section for fetal distress: RR = 
6.83 (95% CI: 1.55–30.4). cases vs. 
controls, respectively.
Neonatal complications: No 
difference between groups.
Sensitivity and specificity of 
oligohydramnios diagnosis for 
Caesarean delivery for fetal distress: 
78% and 74%, respectively.
Kreiser et al. 2001 [180] USA.
Retrospective study. Low-risk 
singleton pregnancies (N = 150) > 
30 wks' gestation with decreased 
AFI. Pregnancies (N = 57) with very 
low AFI (≤ 5 cm); N = 93 with 
borderline AFI (>5 cm but < 2.5th 
percentile).
Compared the impact in 
pregnancies with low AFI 
(intervention) vs. those with 
borderline AFI (controls).
PMR: 0 in both groups [NS]
Locatelli et al. 2004 [116] Italy.
Prospective study. Uncomplicated, 
singleton pregnant women (N = 
3050) with a non-anomalous fetus 
reaching 40 wks' gestation recruited 
from 1997–2000. All women 
underwent semi-weekly monitoring 
of AFI until delivery. 
Oligohydramnios (N = 341).
Compared the rate of 
oligohydramnios in gestations with 
adverse perinatal outcome, 
including 5-min Apgar score < 7; 
umbilical artery pH < 7.0; 
Caesarean section for fetal distress; 
or fetal death (cases) vs. favorable 
outcome (controls).
Oligohydramnios: 33/167 (19.8%) vs. 
308/2883 (10.7%) in cases and 
controls, respectively; P = 0.001).
Morris et al. 2003 [120] UK. University teaching hospital.
Prospective, double-blind cohort 
study. Pregnant women (N = 1584) 
≥40 wks of gestation were 
subjected to ultrasound assessment.
To compare predictive ability single 
ultrasound scan to detect a single 
deepest pool of AFI<2 cm 
(exposed) vs. AFI<5 cm 
(unexposed) in anticipating 
subsequent adverse pregnancy 
outcome.
PMR: 0 in both groups.
An AFI <5 cm but not a single 
deepest pool <2 cm was significantly 
associated with birth asphyxia or 
meconium aspiration.
Sensitivity of AFI < 5 cm for major 
adverse outcome: 28.6%
Myles et al. 1992 [118] USA.
Prospective cohort study. N = 218 
pregnant women on whom AFI was 
performed (N = 125 with greater 
volume in upper quadrants; N = 93 
with greater volume in lower 
quadrants).
Assessed the predictive value of 
distribution of amniotic fluid 
measured by the 4-quadrant 
method, comparing perinatal 
outcomes among women with 
greater amniotic fluid volume in 
upper quadrants (intervention) vs. 
lower quadrants (comparison).
Meconium staining: 32.8% vs. 9.7% in 
intervention vs. comparison groups, 
respectively (P < 0.0001).
1-min Apgar <7: 12.0% vs. 2.2% in 
intervention vs. comparison groups, 
respectively (P < 0.007).
Umbilical arterial pH<7.20: 29.6% vs. 
8.9% in intervention vs. comparison 
groups, respectively (P < 0.0105).
Umbilical venous pH <7.20: 8.9 vs. 
0% in intervention vs. comparison 
groups, respectively (P < 0.0398).
Table 13: Impact of amniotic fluid volume assessment for oligohydramnios and associated interventions on stillbirth and perinatal 
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Sherer et al. 1996 [181] USA.
Retrospective database study. N = 
352 nonhypertensive, nondiabetic 
pregnant women delivering at < 32 
wks' gestation with amniotic fluid 
measurement performed as part of 
BPP <24 hours before delivery.
Assessed association of low AFI 
with fetal movements.
Low AFI associated with reduced 
fetal movements (P < 0.0001).
Higher incidence of 
chorioamnionitis in patients with no 
fetal movements (P < 0.005)
Shoham et al. 2001 [182] Israel.
Matched case-control study. N = 
368 women with gestational 
diabetes mellitus (N = 194 with 
polyhydramnios, AFI>25 cm; N = 
184 women with normal AFI) under 
strict metabolic control enrolled 
from 1995–1996.
To determine whether gestational 
diabetes (GDM) complicated with 
hydramnios is associated with 
higher rates of perinatal morbidity 
and mortality than those with 
normal amniotic fluid (AFI).
No significant differences in rates of 
antepartum fetal death.
Youssef et al. 1993 [119] Egypt.
Observational study. Fetuses (N = 
174) within one wk of delivery.
Compared the impact of the single 
largest vertical pocket 
(oligohydramnios = depth < 1 cm) 
(study group) vs. the 4-quadrant 
amniotic fluid index 
(oligohydramnios ≤5 cm) (controls).
The AFI was more sensitive in 
predicting mortality (87.5%) and the 
following measures of perinatal 
morbidity: low 5-minute Apgar 
score (88.8%), fetal distress during 
labour (86.6%), meconium-stained 
amniotic fluid (63.6%), and the 
presence of fetal growth restriction 
(79.4%).
Table 13: Impact of amniotic fluid volume assessment for oligohydramnios and associated interventions on stillbirth and perinatal 
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based bed rest, in hypertensive pregnant women both
with and without proteinuria (4 RCTs, N = 449 women)
(Additional file 18). Three studies were of good quality,
but only 1 reported stillbirth as outcome, reporting no
impact of hospital-based bed rest versus routine activity at
home on stillbirth (RR = 4.91, 95% CI: 0.24–101.10).
Only 1 RCT (N = 218 women) of the 2 studies comparing
hospital-based bed rest with routine activity at home in
cases of non-proteinuric hypertension reported stillbirth
and neonatal death as a combined measure. There was no
evidence of impact of hospital-based bed rest on this com-
posite measure (RR = 1.96, 95% CI: 0.18–21.34), though
they did report a reduced risk of severe hypertension (RR
= 0.58, 95% CI: 0.38–0.89) and a borderline reduction in
risk of pre-term birth (RR = 0.53, 95% CI: 0.29–0.99)
compared to normal domiciliary activity [LOE: 1++]
In The Netherlands, an RCT [131] compared domiciliary
care to hospital-based care in high-risk pregnant women
(N = 150). There was 1 perinatal death in each group (1/
77 versus 1/74 in home- versus hospital-based groups,
respectively), and the only stillbirth occurred in the domi-
cilary care group (1/77 versus 0/74 in home- versus hospi-
tal-based groups, respectively); the sample was too small
to assess statistical significance [LOE: 1-]. A large RCT
from China [132] (N = 13,006 women) compared a pro-
tocol of self-monitoring at home to a control group man-
aged at hospitals. Both perinatal mortality and fetal
deaths were lower among the self-monitoring group (peri-
natal mortality: 6.30% versus 10.92% in self-monitoring
versus control groups, respectively, P < 0.05; fetal deaths:
3.23% versus 6.34%, respectively, P < 0.05).
Conclusion
The limited evidence available (Grade D evidence) sug-
gests that home-based care for certain subsets of women
with uncomplicated high-risk pregnancy has no apparent
disadvantage compared with hospital-based bed rest and
monitoring in terms of impact on stillbirths and perinatal
mortality. The number of studies on this subject is small,
however, and limited to the conditions of multiple gesta-
tion and hypertensive disorders of pregnancy, exclusively
in high-resource settings. As one RCT above indicated,
bed rest in hospital for non-proteinuric hypertension may
be superior to home-based care [133], but insufficient evi-
dence exists to recommend hospitalization in this case, as
the study was underpowered. The Cochrane review found
that in multiple pregnancy, bed rest (in hospital) appears
to confer little advantage over no modification of physical
activity; bed rest had no impact on rates of perinatal mor-
tality, stillbirth, or pre-term birth, but may improve fetal
growth [127]. The potential cost savings and increased
convenience to women of home-based bed rest and mon-
itoring indicates that further large studies of the efficacy of
bed rest as an intervention as well as monitoring at home
versus in hospital are needed, particularly studies that
include economic analyses of costs to mothers and hospi-
tals.BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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In-hospital fetal surveillance units
Background
A fetal surveillance unit provides a wide range of maternal
and fetal diagnostic tests, often on an outpatient basis, of
particular benefit in identifying and monitoring high-risk
pregnancies. Antenatal fetal surveillance protocols, which
may include multiple surveillance methods at a specified
frequency, have the potential to impact perinatal mortal-
ity, neonatal morbidity, birth weight in cases of fetal
growth problems, rates of prematurity, and length of hos-
pital admission. Assessment of fetal condition can usually
be performed on an outpatient basis, with admission
reserved for delivery, which is usually less disruptive to the
pregnant woman's family [134]. Specially designated
antenatal surveillance units that offer predominantly out-
patient services also offer operating cost savings compared
with standard hospital admission.
Literature-based evidence
Our literature search identified 1 Cochrane review, 1
Cochrane protocol and 2 other intervention studies
(Table 15). A Cochrane review [135] evaluated the use of
antenatal outpatient day care units as an alternative to
inpatient care for women with complicated pregnancy (1
RCT, N = 54 women) [136] (Additional file 19). Day care
unit assessment for non-proteinuric hypertension
reduced subsequent inpatient stay (difference in mean
stay: 4.0 days; 95% CI: 2.1–5.9 days). The rate of induc-
tion of labour was much higher in the hospital-based
inpatient care group compared to the day care unit group
(OR = 4.9, 95% CI: 1.6–13.8). There were no perinatal
deaths in either group [LOE: 1+]. The Cochrane protocol,
for a review currently in progress, proposes to assess the
impact of different specified regimens of fetal surveillance
for impaired fetal growth on maternal and perinatal out-
comes and length of hospital admission [137]. The 2
intervention studies adopted different approaches.
Soothill et al [134] conducted a before-after intervention
study comparing the number and length of antenatal
admissions in the 5 months after the opening of a perina-
tal care unit providing largely outpatient-based services to
records from the 6 months prior to the opening. They
found no significant change in stillbirth rate (6/1294 ver-
sus 8/1372 after versus before, respectively; rate difference
(RD) = 0.0012, 95% CI: -0.0043–0.0067) [LOE: 2+], sug-
gesting that fetal surveillance on an outpatient basis was
equally effective as hospital admission in managing high-
risk pregnancy. Menzies et al. [138] performed a similar
study of all women admitted with pre-eclampsia to a ter-
tiary-level perinatal unit before and after introducing
standardised assessment and surveillance, and reported
that perinatal outcomes did not change [LOE: 2-].
Conclusion
If patients could be consistently monitored on an outpa-
tient basis, obstetricians would be more willing to admit
patients only for delivery, and to perform more fetal
assessments and maternal tests as outpatient services.
Outpatient fetal surveillance offers benefits in terms of
cost and convenience, and could improve health facility
organisation, and improved record-keeping would
streamline obstetric and perinatal audit, data quality for
research, and teaching opportunities [135]. However, the
evidence base for the benefits of outpatient surveillance of
high-risk pregnancies is relatively limited, as the single
Cochrane review on the subject included 1 small RCT that
reported no perinatal deaths (Grade C evidence). The
reduced rates of induction of labour are of interest and
require further trials reporting labour induction rates with
sufficient power to detect differences in subsequent peri-
natal outcomes. At this time, even in high-resource set-
tings, in-hospital fetal surveillance units cannot be
recommended as an intervention to prevent stillbirths.
Monitoring in labour
Use of the partograph
Background
A partograph, alternatively called a partogram, is a simple
pre-printed paper form on which midwives and obstetri-
cians record labour observations. The tool provides a con-
tinuous pictorial overview of the progress of labour, while
monitoring maternal and fetal well-being. The partograph
distinguishes between the latent and active phases of
labour. The active labour section has 2 straight lines called
the alert and action lines. The alert line reflects a modifi-
cation of the mean rate of cervical dilatation of the slowest
10% of primigravid women in the active phase of labour
(1 cm per hour). Slower progress than this crosses the alert
line on the partograph, which may prompt initiation of
the process of transfer to a facility with emergency obstet-
ric capacity in preparation for intervention for prolonged
labour. Depending on the partograph version, the 'action
line' is 2 to 4 hours to the right of the alert line. Labour
crossing this line suggests primary inefficient uterine activ-
ity and prompts immediate appropriate management of
slow progress of labour, usually via amniotomy, oxytocin
infusion, or both.
Some evidence suggests that midwives and physicians
find the partograph practical in terms of ease of use, time
resourcefulness, continuity of care and educational assist-
ance [139], which may contribute to positive maternal
and fetal outcomes. Partographs are also inexpensive and
relatively simple to use, making their use attractive in low-
resource settings where other intrapartum monitoring
technologies are unavailable or prohibitively expensive.
In higher-resource settings, the partograph can be imple-
mented alongside other fetal surveillance tests such as car-BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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diotocography to provide more information for decision-
making. However, some practitioners view the partograph
as inappropriately restrictive and formulaic, prompting
intervention prematurely [139], factors which could
impact both clinical and maternal psychological out-
comes. Various versions of the partograph are marked by
different slope and position of the action line, which is
likely to impact labour augmentation interventions, Cae-
sarean section rates, and maternal satisfaction.
Literature-based evidence
We identified 1 Cochrane review including 5 RCTs and
quasi-RCTs (N = 6963 women), and 3 intervention/obser-
vational studies (Table 16). The Cochrane review [140]
compared the impact of use of the partograph in compar-
ison with no partograph, as well as different versions of
the partograph, for monitoring the progress of spontane-
ous labour at term (Additional file 20). None of the
included studies reported intrapartum stillbirth rates,
though several reported neonatal outcomes. The ran-
domised controlled trials (RCTs) in the review that com-
pared partograph use to no partograph use (2 trials; N =
1590 women)[141,142] showed no impact of partograph
use on Caesarean section rate (risk ratio (RR) = 0.64, 95%
confidence interval (CI): 0.24–1.70), instrumental vagi-
nal delivery (RR = 1.00, 95% CI: 0.85–1.17) or Apgar
score < 7 at 5 minutes (RR = 0.77, 95% CI: 0.29–2.06).
The Cochrane review [140] also compared the impact of
different versions of the partograph with different action
line placement on labour outcomes. Two RCTs, both con-
ducted in high-resource settings, compared different par-
tograph versions with the action line either 2 hours or 4
hours after the alert line (N = 3601 women) [143,144],
and found no difference in Caesarean section rates
between labours monitored with the 2 different parto-
graphs (RR = 1.06, 95% CI: 0.85–1.32 [NS]). Women in
the 2-hour action line group were significantly more likely
Table 14: Impact of home versus hospital-based bed rest and monitoring in high-risk pregnancy on stillbirth and perinatal mortality
Source Location and Type of Study Intervention Stillbirths/Perinatal Outcomes
Reviews and meta-analyses
Crowther 2001 [127] Zimbabwe, Finland, Australia.
Meta-analysis (Cochrane). 6 RCTs 
included (N = 1431 women).
Compared pregnancy outcomes 
among women with a multiple 
pregnancy and their babies who were 
offered bed rest in hospital 
(intervention) vs. admission to 
hospital only if complications occurred 
(controls).
SBR: OR = 0.89 (95% CI: 0.43–
1.85) [NS].
[14/698 vs. 16/733 in intervention 
and control groups, respectively].
PMR: OR = 1.14 (95% CI: 0.65–
2.01) [NS].
[26/694 vs. 24/733 in intervention 
and control groups, respectively].
Meher et al. 2005 [130] Zimbabwe.
Cochrane review. 1 RCT included 
(N = 218 women).
To assess the effects on the mother 
and the baby of some bed rest in 
hospital (intervention) vs. routine 
activity at home (controls) for primary 
treatment of hypertension during 
pregnancy.
SBR: RR = 4.91 (95% CI: 0.24–
101.10) [NS].
[2/110 vs. 0/108 in intervention 
and control groups, respectively].
PMR: RR = 1.96 (95% CI: 0.18–
21.34) [NS].
[2/110 vs. 1/108 in intervention 
and control groups, respectively].
Intervention studies
Monincx et al. 1997 [131] The Netherlands (Amsterdam). 
The Academic Medical Centre.
RCT. N = 150 women recruited 
between September 1992 and June 
1994 (N = 76 intervention group, 
N = 74 controls).
To compare the outcomes of high-risk 
pregnancy monitored antenatally at 
home via domiciliary care 
(intervention) vs. hospital admission 
(controls).
SBR: 1/77 (1%) vs. 0/74 in 
intervention and control groups, 
respectively.
PMR: 1/77 vs. 1/74 in intervention 
and control groups, respectively.
[No authors listed] 1990 [132] China (Shanhai). 6 hospitals.
RCT. Women (N = 13006) of at 
least 30 wks' gestation (N = 6,506 
intervention group, N = 6,500 
controls).
Compared the impact on PMR of self-
monitoring at home (intervention) vs. 
controls (without self-monitoring).
PMR: 6.30% vs. 10.92% in 
intervention and control groups, 
respectively (statistically 
significant).
Fetal death (miscarriage + SB): 
3.23% vs. 6.34% in intervention and 
control groups, respectively 
(statistically significant).BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
Page 34 of 48
(page number not for citation purposes)
to receive oxytocin augmentation (RR = 1.14, 95% CI:
1.05–1.22). One RCT, also in a high-resource setting,
compared a 2-hour versus a 3-hour action line (N = 617
women)[143]. There was no difference in Caesarean sec-
tion (RR = 0.78, 95% CI: 0.51–1.18). Maternal satisfac-
tion with care was higher in the 2-hour action line group
than the 3-hour action line group (RR = 0.49, 95% CI:
0.27–0.90). There was no difference in neonatal out-
comes. One RCT in a high-resource setting compared the
impact of partographs with a 3-hour versus a 4-hour
action line (N = 613) [143]. The Caesarean section rate
was significantly lower in the 4-hour action line group
(RR = 1.70, 95% CI: 1.07–2.70) but there was no differ-
ence in neonatal outcomes. One RCT in a low-resource
setting compared a partograph with no action line (alert
line only) to a partograph with an action line (N = 694
women) [145]. The Caesarean section rate was lower in
the group with no action line (RR = 0.68, 95% CI: 0.50–
0.93), but there was no difference in neonatal outcomes.
The review also pooled the results from 3 RCTs to com-
pare shorter (2-hour action line or alert line only) versus
longer time-to-intervention (4-hour action line or alert
plus action lines) and found no differences between the
groups for Caesarean section rate, Apgar score or instru-
mental delivery, but early intervention in the low-resource
setting reduced the Caesarean section rate.
A large multicentre study [146] compared the impact of
partograph use in multiple hospitals in Southeast Asia (N
= 35,484 women). The reported stillbirth rate was 0.3% in
the group for which the partograph was used, versus 0.5%
in the control group; this small difference was not
assessed for statistical significance because partograph use
was introduced in stages. A sub-study using the same
WHO dataset of breech birth management using the par-
tograph [147] found a non-significant decrease in intra-
partum stillbirth after the introduction of the partograph
compared with before (1.1% versus 1.9% after versus
before, respectively).
In Indonesia, Fahdhy et al [148] compared the use of mid-
wives trained to employ the partograph versus standard
midwifery care without the partograph. Seventy-one of
304 labours plotted on the partograph progressed beyond
the alert line; the study reported significant decreases in
obstructed labour, oxytocin use, and Apgar score less than
7 at 1 minute, but there were only non-significant reduc-
tions in fetal death and early neonatal death [adjusted OR
for fetal death = 0.62, 95% CI: 0.17–2.19 (NS); adjusted
OR for neonatal death = 0.70, 95% CI: 0.16–3.11(NS)].
Conclusion
Overall, there were no significant differences in maternal
or perinatal outcomes with the use of partograph versus
no partograph, and no evidence that any particular ver-
sion of the partograph is better than another in preventing
perinatal mortality. Partographs may be comparatively
more effective in low-resource settings, as the studies from
Africa and Mexico in the Lavender review [140], as well as
data from Southeast Asia [146] that showed reduced Cae-
sarean section rates with use of the partograph and early
intervention for slow progress of labour. The data from
Southeast Asia and Indonesia also showed trends toward
improved birth outcomes [146]. Our overall assessment
of the grade of evidence of studies of partograph is Grade
Table 15: Impact of a fetal surveillance unit on stillbirth and perinatal outcomes
Source Location and Type of Study Intervention Stillbirths/Perinatal 
Outcomes
Reviews and meta-analyses
Kröner et al. 2001 [135] UK.
Cochrane review. 1 RCT included 
(N = 54 women).
Compared the impact on perinatal 
mortality of antenatal day care units 
(intervention) vs. inpatient care (controls) 
for women with complicated pregnancy.
PMR: OR not estimable.
[0/30 vs. 0/24 in intervention and 
control groups, respectively].
Intervention studies
Menzies et al. 2007 [138] Canada. Tertiary perinatal unit.
Before-after design. Pregnant 
women (N = 700) admitted to 
hospital with pre-eclampsia.
Compared the impact after (intervention) 
and before (controls) introducing 
standardised assessment and surveillance 
for pre-eclampsia.
SBR: OR = 1.47 (95% CI: 0.50–
4.34, P = 0.602) [NS]
10/405 vs. 5/295 in the 
intervention and control groups, 
respectively.
Soothill et al. 1991 [134] UK (London). Kings College.
Before-after design. Pregnancies (N 
= 2666).
Compared the number and length of 
antenatal admissions for 6 months before 
compared to 5 months after the opening of 
a fetal surveillance unit.
SB: 6/1294 vs. 8/1372 in before 
and after periods, respectively; (P 
= 0.336) [NS]BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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C. Given the limitations of the studies included and the
potential impact of organisational issues, e.g. guidelines
on partograph use, a large cluster-RCT in low-resource set-
tings is recommended to compare partograph versus no
partograph use, specifically including stillbirths as a
reported outcome.
Intrapartum cardiotocography with and without pulse 
oximetry
Background
Methods to assess fetal heart rate and levels of oxygena-
tion of fetal blood are monitoring strategies intended to
identify early signs of fetal compromise as a result of oxy-
gen shortage, or fetal hypoxia [2]. Severe and prolonged
hypoxia is associated with stillbirth, early neonatal death,
and long-term physical or mental disability, including cer-
ebral palsy, if the baby survives. Fetal heart rate patterns
are classified as either reassuring, nonreassuring or abnor-
mal, considering heart rate baseline, variability, and decel-
erations. While nonreassuring tests may become
reassuring with simple change in maternal position,
abnormal fetal heart rate alterations or low blood oxygen
levels are a frequent indication for Caesarean or instru-
mental delivery [149].
In many hospitals in high-income countries including the
US and Canada, cardiotocography is widely used to mon-
itor fetal heart rate in labour, though intermittent auscul-
tation (periodic listening to the fetal heart rate using a
stethoscope or handheld Doppler device) is occasionally
performed. In addition to external cardiotocography,
which can be employed continuously or intermittently
during labour, internal cardiotocography can be per-
formed by attaching a sensor to the fetal presenting part,
usually its head. This can be done only if the membranes
are ruptured, as electrode must be embedded in the baby's
scalp. Intermittent auscultation via stethoscope or hand-
held Doppler is more common than electronic fetal mon-
itoring methods in low-resource settings where fetal heart
rate monitoring is available.
Currently, cardiotocography is recommended in high-risk
pregnancy and labours induced or augmented with oxy-
tocin [150]. Because of the poor ability of cardiotocogra-
phy alone to detect true fetal distress, the practice of pulse
oximetry is thought to provide additional helpful infor-
mation to corroborate cardiotocographic traces. Pulse oxi-
metry is intended as a follow-up procedure in the presence
of a nonassuring cardiotocographic test, and is intended
to improve the accuracy of the assessment of fetal well-
being in the intrapartum period [151]. In this procedure,
a sensor is attached via a clip to the fetus, generally on the
scalp, cheek, temple, or back; oxygenation values exceed-
ing 30% are considered reassuring even when a cardio-
graphic trace is nonreassuring [152]. While non-
reassuring tests may become reassuring with simple
change in maternal position, abnormal fetal heart rate
alterations are a frequent indication for Caesarean or
instrumental delivery [149].
There is some danger that improper interpretation of car-
diotocographic tracings can lead to inappropriate inter-
vention, or false reassurance that delays necessary
intervention. There is a need for sensitive and specific
methods of using cardiotocography, potentially in con-
junction with pulse oximetry, to improve detection of
fetal compromise due to hypoxia. Improved detection of
hypoxia, primarily by expediting delivery, could improve
outcomes and prevent stillbirth in these instances.
Literature-based evidence
The literature review identified two Cochrane reviews on
intrapartum cardiotocography, one Cochrane review
examining pulse oximetry in conjunction with cardioto-
cography, and two other observational/interventional
studies (Table 17). In a large Cochrane review (12 trials,
N>37,000 women), Alfirevic and Devane [2] evaluated
RCTs and quasi-RCTs comparing continuous cardiotocog-
raphy in labour (with and without fetal blood sampling)
with no fetal monitoring, intermittent auscultation, or
intermittent cardiotocography (Additional file 21). Com-
pared to intermittent auscultation, continuous cardioto-
cography showed no significant difference in overall PMR
(11 trials, N = 33,513 women, RR = 0.85, 95% CI: 0.59–
1.23), but did significantly reduce the risk of neonatal sei-
zures (RR = 0.50, 95% CI: 0.31–0.80, 9 trials, N = 32,386)
although no significant difference was detected in cerebral
palsy (RR = 1.74, 95% CI: 0.97–3.11, 2 trials, N = 13,252).
Continuous cardiotocography was associated with an
increased risk of Caesarean delivery (RR = 1.66, 95% CI:
1.30–2.13, 10 trials, N = 18,761 women) and instrumen-
tal vaginal birth (RR = 1.16, 95% CI: 1.01–1.32, 9 trials, N
= 18,151 women). Results of subgroup analysis were con-
sistent with overall results presented above, and the addi-
tion of fetal blood sampling appeared to have no effect on
outcomes [LOE: 1+]. A new Cochrane review assessing
cardiotocography versus intermittent auscultation of fetal
heart for assessment of fetal well-being is in progress
[153].
Another Cochrane review [154] (4 RCTs, N = 9829
women) compared fetal electrocardiogram ST waveform
analysis with alternative methods of fetal monitoring dur-
ing labour, including continuous cardiotocography
(Additional file 22). In comparison to continuous cardi-
otocography alone, the use of adjunctive electrocardio-
gram analysis reduced the risk of neonatal acidosis at birth
(3 trials, N = 8872 women; RR = 0.64, 95% CI: 0.41–1.00,
N = 8108 babies) and neonatal encephalopathy (3 RCTs,
RR = 0.33, 95% CI: 0.11–0.95). Procedurally, adjunctiveBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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electrocardiogram evaluating the ST segment was associ-
ated with fewer fetal scalp samples during labour (3 RCTs,
RR = 0.76, 95% CI: 0.67–0.86) and fewer instrumental
vaginal deliveries (3 RCTs, RR = 0.87, 95% CI: 0.78–0.96),
but had no impact on Caesarean section rates or Apgar
score < 7 at 5 minutes. Use of another electrocardiogram
method, time-interval analysis, showed no benefit other
than a trend towards fewer operative deliveries (1 RCT, RR
= 0.87, 95% CI: 0.76–1.01); there was no significant
increased risk of perinatal death in the electrocardiogram
plus cardiotocography group versus the group with cardi-
otocography alone (RR = 2.29, 95% CI: 0.59–8.83) [LOE:
1++].
A third Cochrane review [149] assessed RCTs that compar-
ied maternal and fetal outcomes after fetal pulse oximetry
was used in labour (with or without concurrent use of car-
diotocography or auscultation), compared with cardioto-
cography alone (Additional file 23). Adjunctive fetal pulse
oximetry with cardiotocography was associated with sig-
nificantly decreased rates of Caesarean section for nonre-
assuring fetal status compared to cardiotocography alone
in groups without fetal blood sampling prior to study
entry (RR = 0.68, 95% CI: 0.47–0.99), and in groups with
fetal blood sampling prior to study entry (RR = 0.03, 95%
CI: 0.00–0.44). Based on 2 trials reporting outcomes,
there was no impact of adding fetal pulse oximetry to car-
Table 16: Impact of use of the partograph in stillbirth and perinatal outcomes
Source Location and Type of Study Intervention Stillbirths/Perinatal Outcomes
Reviews and meta-analyses
Lavender et al. 2008 [140] England and South Africa.
Meta-analysis (Cochrane). 5 RCTs 
included; 3 reported serious 
neonatal morbidity or PMR. N = 
6963 women.
Assessed the use of partograph vs. no 
partograph; and compared impact of 
different versions of partograph (e.g. 
partogram with 2-hr, 3-hr, 4-hr, or no 
action line).
Serious neonatal morbidity or PMR: 
OR not estimable.
[0/1805 vs. 0/1796 in the 2-hour vs. 
4-hour action line groups, 
respectively].
Intervention studies
Fahdhy 2005 [148] Indonesia (Medan City).
Cluster RCT. 20 midwives in 
maternity homes. N = 626 
pregnant women with vertex 
presentations (N = 304 
intervention, N = 322 controls).
Assessed the impact of the use of the 
WHO partograph by trained midwives 
(intervention) vs. standard midwifery care 
without partograph (controls). 92% of 
partographs correctly completed; N = 71 
had graph beyond alert line. 42/71 
referred to hospital.
Fetal death: adj. OR = 0.62 (95% CI: 
0.17–2.19) [NS]
[5/304 vs. 7/302 in intervention vs. 
control groups, respectively.]
END: adj. OR =  0.70 (0.16–3.11) 
[NS] 
[3/304 vs. 7/302 in intervention vs. 
control groups, respectively.]
Significant decreases in obstructed 
labour, oxytocin use:, Apgar <7 at 1 
min: No difference in Caesarean 
section rate, Apgar <7 at 5 min, or 
prolonged labour.
Lennox 1998 [147] Indonesia, Thailand, Malaysia. 
Hospital-based study. Multicentre.
Before-after study. 8 hospitals. N = 
1740 breech presentation 
pregnancies (N = 817 after, N = 
923 before).
Assessed the impact of use of the 
partograph with an agreed labour-
management protocol on perinatal 
outcomes.
Intrapartum SB (breech): 1.1% vs. 
1.9% after vs. before, respectively. 
[NS]
Prolonged labour: Significant 
reduction with partograph (P < 
0.05)
WHO 1994 [146] Indonesia, Thailand, Malaysia. 
Hospital-based study. Multicentre.
Quasi-RCT. 8 hospitals. N = 
35,484 women.
Assessed the impact of use of the 
partograph with an agreed labour-
management protocol on perinatal 
outcomes.
Intrapartum SB: 0.3% vs. 0.5% in 
intervention vs. control groups, 
respectively.
Prolonged labour: 3.4% vs. 6.4% in 
intervention vs. control groups, 
respectively.
Oxytocin augmentation: 9.1% vs. 
20.7% in intervention vs. control 
groups, respectively.
Emergency Caesarean sections: 
8.3% vs. 9.9% in intervention vs. 
control groups, respectively.BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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diotocography on fetal/neonatal death (RR = 0.93, 95%
CI: 0.20–4.44) [LOE: 1++].
Conclusion
Although there are several studies of fetal pulse oximetry
and intrapartum cardiotocography, few reported stillbirth
or perinatal mortality as outcomes. The available results
show no statistically significant impact on stillbirths or
perinatal mortality, whether cardiotocography is used
alone or in conjunction with fetal pulse oximetry in
labour. Continuous cardiotocography appears associated
with increased rates of operative delivery and lower rates
of neonatal seizures compared to no or intermittent cardi-
otocography, but has no demonstrated impact on rates of
perinatal mortality acidosis, dystocia, or long-term physi-
cal or developmental outcomes. There is currently no evi-
dence of benefit from randomised or quasi-randomised
studies for intrapartum cardiotocography alone or in con-
junction with electrocardiogram or fetal pulse oximetry in
preventing stillbirth.
One drawback of intrapartum cardiotocography is that its
poor predictive value of true fetal distress and hypoxia is
not sufficiently enhanced by any adjunctive technologies
at this time. Pulse oximetry appears safe, though long-
term developmental studies have not been performed, but
it does not have any clear impact on stillbirths or perinatal
mortality [149]. Adjunctive electrocardiogram possibly
reduces neonatal encephalopathy, academia, and instru-
mental delivery, but these findings need additional
research to verify. Minimally invasive technologies and
tests are needed in addition to intrapartum cardiotocogra-
phy to more accurately identify intrapartum hypoxia and
dystocia.
There are robust studies and Cochrane reviews on fetal
pulse oximetry and intrapartum cardiotocography (Grade
B evidence). The non-significant impact of cardiotocogra-
phy with or without fetal pulse oximetry on stillbirth/peri-
natal mortality in these studies suggests no evidence of
benefit. In high-income countries, documented stillbirth
rates, particularly stillbirths associated with intrauterine
asphyxia, in high-income countries have followed increas-
ing prevalence of cardiotocographic fetal monitoring with
Caesarean section for fetal distress [155-157], though this
association may be confounded. Electronic fetal monitor-
ing (with access to operative delivery) may an important
tool in the arsenal of strategies to prevent stillbirth,
though this is unproven. More precise tests for fetal dis-
tress and indications for Caesarean section are needed.
Summary
Although a reasonable number of Cochrane reviews and
RCTs were available which assessed the impact of one or
more implementation strategies for many screening and
monitoring interventions, none of the interventions we
reviewed demonstrated convincing evidence of impact on
stillbirths or perinatal mortality. A number of studies that
did report statistically significant impact on stillbirth or
perinatal mortality, or which suggested large magnitude
differences between intervention and control/comparison
groups, lacked sufficient rigor to justify recommending
the routine use of the interventions evaluated.
The evidence for all interventions reviewed in this paper is
summarised in Table 18. Of the range of monitoring inter-
ventions evaluated, fetal movement counting and Dop-
pler monitoring were promising for further evaluation in
high-risk pregnancies in low-resource settings. Low amni-
otic fluid measurements were strongly predictive of still-
birth, but interventions to restore adequate amniotic fluid
volume or to deliver the baby based on identification of
oligohydramnios have not been systematically tested to
conclude whether amniotic fluid assessment is a useful
diagnostic tool that leads to actions which prevent still-
birth.
Research gaps
Despite the existence of many tools, devices, and tech-
niques for monitoring pregnancy for complications, there
is a dearth of rigorous evidence that any screening and
monitoring intervention has a direct impact on stillbirth
rates in unselected and low-risk populations. This stems
from several common shortcomings in the design and
interpretation of studies investigating the use of screening
and monitoring techniques. First, the small size and insuf-
ficient rigor of many screening and monitoring studies to
date renders them underpowered to detect significant dif-
ferences in perinatal mortality subsequent to their imple-
mentation. Many studies assessing the impact of the
interventions covered in this review did not report still-
births or perinatal mortality at all. For virtually all the
interventions included in this review (with the exception
of x-ray pelvimetry), there is a need for RCTs sufficiently
powered to detect statistically significant impact on still-
birth or perinatal mortality, if such differences exist. Sec-
ond, for screening and monitoring interventions to reduce
stillbirth incidence, they must effectively identify women
at higher risk of stillbirth in time for an appropriate and
effective intervention to be provided. Most studies we
reviewed limited their analysis to the first step of success-
ful screening or monitoring: detection of women at
increased risk of stillbirth or perinatal death. A number of
studies showed that positive test results corresponded
fairly well with increased risk of adverse pregnancy out-
come. However, a trial of an otherwise effective screening
method will show no impact on stillbirths if the subse-
quent intervention fails to prevent stillbirth, either
because intervention is ineffective or provided too late. In
most of the studies we reviewed, few women whoBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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Table 17: Impact of intrapartum cardiotocography with or without pulse oximetry on stillbirth and perinatal outcomes
Source Location and Type of 
Study
Intervention Stillbirths/Perinatal Outcomes
Reviews and meta-analyses
East et al. 2007 [149] USA, Australia, Germany.
Meta-analysis (Cochrane). 4 
RCTs included (N = 1789).
To compare the effectiveness and 
safety of fetal pulse oximetry + 
cardiotocography (intervention) vs. 
conventional surveillance techniques 
(cardiotocography only).
Fetal death (miscarriage+SB)/NMR: RR = 
0.93 (95% CI: 0.20–4.44) [NS].
[3/942 vs. 3/847 in intervention and control 
groups, respectively] for gestation from 36 
weeks and fetal blood sampling (FBS) not 
required prior to study entry.
Neilson 2006 [154] Sweden, Finland, UK, Hong 
Kong, Netherlands, Singapore.
Meta-analysis (Cochrane). 4 
RCTs included (N = 9829).
To compare the effects of analysis of 
fetal ECG waveforms during labour 
(intervention) vs. alternative methods 
of fetal monitoring (no ECG) 
(controls).
PMR: RR = 2.29 (95% CI: 0.59–8.83) [NS].
[6/4953 vs. 2/4876 in intervention and 
control groups, respectively].
Alfirevic et al. 2006 [2] Athens, Copenhagen, Denver, 
Dublin, Australia, Pakistan, 
USA, Sheffield.
Meta-analysis (Cochrane) 11 
RCTs included (N = 33,513).
To assess the effectiveness of 
continuous cardiotocography during 
labour (intervention) vs. intermittent 
auscultation (controls).
PMR: RR = 0.85 (95% CI: 0.59–1.23) [NS].
[50/16849 vs. 57/16664 in intervention and 
control groups, respectively].
Observational studies
Seelbach Gobel 1999 [183] Germany. Multicentreed study 
involving 3 obstetric centres.
Observational study. N = 400 
deliveries monitored by fetal 
pulse oximetry.
Compared the durations of different 
fetal arterial oxygen saturations in 
neonates with a pH < 7.15 vs. ≥ 7.15, 
base excess < -12 mmol/L vs. > -12 
mmol/L in the umbilical artery post 
partum and in neonates with an 
Apgar score < 7 vs. ≥ 7.
Duration of low fetal arterial oxygen 
saturation: significantly longer in neonates 
with a 1-minute Apgar score <7 vs. ≥ 7, with 
pH < 7.15 vs. = 7.15 and with base excess < 
-12 mmol/L vs. ≥ -12 mmol/L.
Duration of medium fetal arterial oxygen 
saturation: no significant differences 
between the groups.
Duration of high fetal arterial oxygen 
saturation: significantly shorter for children 
with pH < 7.15 vs. ≥ 7.15 and with base 
excess < -12 mmol/L vs. ≥ -12 mmol/L; no 
significant difference in children with Apgar 
score < 7 vs. ≥ 7.
The duration of low fetal arterial oxygen 
saturation proved to be the best predictor 
of a decline of scalp pH between 2 fetal scalp 
blood samples. The pH declined significantly 
with a longer duration of low fetal arterial 
oxygen saturation (0.02 per 10 minutes). No 
decrease of pH by more than 0.05 was 
observed unless fetal arterial oxygen 
saturation had remained at ≤ 30% for ≥ 10 
minutes.
Stiller et al. 2002 [184] Switzerland.
Test sensitivity and specificity 
analysis. N = 107 sets of 
measures.
To determine the sensitivity and 
specificity for acidosis of intrapartum 
fetal oxygen saturation measured by 
reflectance pulse oximetry.
Mean fetal oxygen saturation was 42.8%, 
over the mean 132 minutes of 107 
recordings.
Depending on stage and umbilical artery 
parameter, fetal oxygen saturation cutoffs 
were 33% to 36%, with sensitivities of 0.67 
to 0.8 and specificities of 0.62 to 0.90.
Umbilical artery values tended to be less 
favorable at SpO2 levels < 40%; above 40% 
no unfavorable values were reported.BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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screened positive were treated according to an established
protocol. This flaw precludes assessment of whether the
lack of impact of any given screening technique is attrib-
utable to a failed screening method or a failed interven-
tion. This fact highlights the need for time-to-decision and
time-to-intervention studies, as well as analyses that con-
sider which interventions are employed, and protocols for
employing them, subsequent to adverse findings of
screening and monitoring studies. The quality, appropri-
ateness, and timeliness of the intervention care provided
must also be considered along with the effectiveness of
screening or monitoring in detecting true complications.
In addition to these tests of diagnostic accuracy and inter-
vention effectiveness, other types of studies are also
needed, including innovative pilot studies, safety studies,
and effectiveness trials, to bolster the weak evidence base
for screening and monitoring interventions during labour
(Table 19). In high-income countries, there is a particular
need for better understanding of placental pathophysiol-
ogy, as up to half of unexplained stillbirths show signs of
growth restriction, much of which is attributed to placen-
tal insufficiency [158]. Placental dysfunction is often
observed in other major known causes of stillbirth includ-
ing pre-eclampsia and abruption, suggesting the need for
accurate placental function or placental biomarker screen-
ing tests, especially those appropriate for use in unselected
populations. One such test in early pregnancy which
measures pregnancy associated plasma protein-A has
been associated with a 40–50-fold increase in risk of still-
birth due to placental dysfunction in a selected popula-
tion, but it is unclear what interventions could prevent
stillbirth among women with such positive test results
[159]. Appropriate management of pregnancies compli-
cated by placental dysfunction and/or fetal growth restric-
tion requires further research, particularly when detected
too early in pregnancy to consider early delivery.
Additional questions surround which screening and mon-
itoring interventions could be most effective in low-/mid-
dle-income country settings where 98% or more of the
global burden of stillbirths occurs [160]. Screening and
monitoring are often technology-dependent, as illustrated
by the cardiotocographic machine required for the BPP,
CST, and NST; and the use of video ultrasound machines
for amniotic fluid assessment. This makes some of these
interventions impractical or unaffordable in low-resource
or remote settings at the present time. However, certain
technologies, such as handheld Doppler ultrasound and
video ultrasound scanning machines, are increasingly
available in low-resource settings; there is a need for stud-
ies to define the most cost-effective ways of using these
and other available technologies to identify high-risk
pregnancies. Additionally, other techniques, such as fetal
movement monitoring and the partograph, require little
investment other than training of midwives or mothers,
and may be appropriate for use in high-risk pregnancies,
if these pregnancies can be identified and if the use of
these techniques result in improved outcomes, which has
not yet been conclusively demonstrated. Additionally,
there is some potentially promising evidence that fetal
surveillance typically provided on an inpatient basis,
often with bed rest, for high-risk pregnancies can be
offered on an outpatient basis with bed rest or reduced
activity at home without deleterious impact on pregnancy
outcomes; this evidence requires confirmatory effective-
ness trials in low-resource settings before programmatic
adoption of this approach could be recommended.
Practicality, logistical feasibility, and cost-effectiveness are
chief concerns in many low-resource areas. Where ANC
services are available and widely utilised, the prospects for
identifying and monitoring high-risk pregnancy improve.
Along with interventions that improve detection of risk
factors and complications, improved management and
referral of women with complications are critical to man-
age obstetric risk in low-/middle-income countries.
Unfortunately, in areas where ANC attendance is poor,
few of these screening and monitoring techniques are
likely to be implementable.
Implications for programmes and clinical practice
A few monitoring approaches showed promise for use in
high-risk pregnancies, including fetal movement monitor-
ing and umbilical Doppler velocimetry. Before recom-
mending these interventions for widespread use, further
large RCTs of sufficient rigour to detect differences in still-
birth and perinatal outcomes are needed to determine the
utility and effectiveness of these monitoring approaches
and interventions used after positive tests.
This review identified several interventions – for example,
amniotic fluid measurement for signs of oligohydram-
nios, especially as pregnancy approaches or exceeds term;
routine ultrasound scanning, and intrapartum cardioto-
cography – that are in widespread use in high-resource set-
tings, but for which rigorous evidence is lacking. For these
interventions, their continued use is reasonable even
though the evidence base for impact on stillbirths is lack-
ing. Intrapartum cardiotocography in particular has been
shown in RCTs to elevate the risk of operative delivery.
Prevailing wisdom credits cardiotocography and available
Caesarean section with the diminution of stillbirth rates
in high-income countries in recent decades; however, the
role of cardiotocography in reducing stillbirth should be
confirmed with more rigorous evidence. Efforts to achieve
glycaemic control in cases of maternal diabetes mellitus
are also encouraged, despite the lack of strong evidence
showing an impact of such interventions on stillbirth, on
the grounds that women with good glycaemic controlBMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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experience fewer complications and negative outcomes of
pregnancy.
Particularly in pregnancies deemed high-risk based on
screening test results, clinical progression of pregnancy, or
reproductive history, multiple antepartum testing modal-
ities can minimise deficiencies in sensitivity and predic-
tive value when used in combination to assess fetal well-
being and abnormalities. The BPP reflects one standard-
ised strategy by which tests of fetal well-being have been
packaged to permit a more comprehensive assessment of
fetal well-being. In cases where one test raises the possibil-
ity that a pregnancy is high-risk, multiple tests of fetal
well-being should be considered if time allows, along
with the patient's overall clinical history, to determine the
appropriateness of intervention. Multiple tests are recom-
mended in many protocols for identifying and making
clinical decisions about management of pregnancies with
suspected fetal growth restriction [161]. In these cases the
collective results of a battery of tests including all the com-
Table 18: Collective grading of evidence for impact of monitoring interventions in pregnancy on stillbirth and related perinatal 
outcomes
Evidence of no or 
negative impact
(leave out of programmes)
Uncertain evidence
(need for additional 
research before including 
in programmes)
Some evidence
(may include in 
programmes, but further 
evaluation is warranted)
Clear evidence
(merits inclusion in 
programmes)
Pregnancy risk screening X
Fetal movement counting X X
(for high-risk pregnancies)
Ultrasound scanning X
Doppler velocimetry X (uterine artery and 
unselected populations)
X (umbilical artery and 
ductus venosus in high-risk 
pregnancies)
Pelvimetry X
Detection and management 
of diabetes mellitus
X
Antepartum fetal heart rate 
monitoring with 
cardiotocography (NST, 
CST)
X
Fetal BPP scoring X
Vibroacoustic stimulation X
Amniotic fluid volume 
assessment
X (oligohydramnios clear 
risk factor)
Home vs. hospital bed rest 
and monitoring for high-
risk pregnancies
X
In-hospital fetal surveillance 
unit
X
Use of the partograph X
Intrapartum 
cardiotocography and pulse 
oximetry
X (based largely on 
observational evidence)BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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ponents of the BPP and Doppler velocimetry, as well as
ultrasound biometry, can be informative in decision-mak-
ing to maximise gestational age and inform the strategic
timing of corticosteroid administration and early delivery
via induction or Caesarean section. However, conflicting
test results – a recent study showed only 44.5% concord-
ance between BPP and Doppler assessments of compro-
mise in growth-restricted fetuses – can complicate
interpretation [162].
Recommendations for clinical decision-making protocols
and introduction of interventions in low-/middle-income
countries are more difficult. Resource constraints preclude
the implementation of many of the interventions
reviewed in this paper. The interventions requiring the
lowest investment in resources and training – fetal move-
ment monitoring and the partograph – show some evi-
dence of benefit in high-risk pregnancies, but more
studies are needed. Where safe Caesarean section is avail-
able, ensuring that intermittent or continuous intrapar-
tum fetal heart rate monitoring is performed may improve
targeting of Caesarean section while improving birth out-
comes.
Screening and monitoring interventions cannot be effec-
tive without responsive, quality care and careful clinical
management, particularly for high-risk pregnancies.
Health systems quality improvement activities, including
boosting provider skill in interpreting test results and
determining appropriate intervention, timely response
including swift referral, and evaluative strategies to docu-
ment outcomes after intervention are essential comple-
mentary activities to ensure that an effective screening or
Table 19: Research gaps
Pilot/cohort studies of interventions
• Alternative imaging or diagnostic technologies (alternatives to X-ray pelvimetry) to predict cephalopelvic disproportion in the antepartum 
period
• Pathophysiology of impaired placentation and identification of clinical markers of poor placentation/perfusion to develop tests of stillbirth risk
• Development of optimal methodologies for vibroacoustic stimulation (frequency, placement, amplitude, etc), and studies of efficacy and 
predictive reliability
• Safety of vibroacoustic stimulation (auditory function, cognitive development) and pulse oximetry (cognitive development)
• Interventions to prevent and treat oligohydramnios, particularly in cases of intact membranes
• Non-interventional sensitivity, specificity, and predictive value testing of untested screening techniques in unselected populations (low- and 
high-risk pregnant women)
• Development of predictive variables for stillbirth at term
• Low-tech strategies, such as the partograph, for identifying high-risk pregnancies in low-resource settings
• New adjunctive techniques to improve the positive predictive value of fetal distress and hypoxia of cardiotocography
Well-designed RCTs of interventions powered to detect stillbirth rates
• Community-based pregnancy risk screening schemes
• Formal fetal movement monitoring in high-risk pregnancies
 Comparisons of different methods
 Impact of timing from monitoring-to-intervention on perinatal mortality
• Optimal combinations of tests to screen for fetal growth restriction
• Optimal management of fetal growth restriction and timing of delivery
• Ultrasound assessment of placental appearance (lesions and calcifications) in high-risk pregnancy
• Ability of uterine artery Doppler ultrasound in combination with other testing for pre-eclampsia prediction and subsequent development of 
prevention measures for women at highest risk
• Optimising glycaemic control in managing diabetes mellitus in pregnancy
• Assessment of stillbirth risk in instances of gestational diabetes and impaired glucose tolerance (little data compared to pre-existing diabetes 
mellitus)
• Usefulness of BPP in identifying fetal compromise
• Vibroacoustic stimulation studies in labour
• Impact of in-hospital fetal surveillance units on stillbirth outcomes
• Partograph versus no partograph use
Effectiveness and cost-effectiveness trials in large populations/at scale
• Cost-benefit analyses of routine ultrasound for gestational age dating and multiple pregnancy detection in resource-poor settings
• Cost-effectiveness studies of fetal surveillance units in hospitals
• Safety of out-of-hospital bed rest and outpatient fetal surveillance in high-risk pregnancies in resource-poor settings (including economic 
analyses)BMC Pregnancy and Childbirth 2009, 9(Suppl 1):S5 http://www.biomedcentral.com/1471-2393/9/S1/S5
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monitoring technique translates to measurable improve-
ments in perinatal mortality outcomes.
Conclusion
Screening pregnancies to identify risk factors, complica-
tions, or indications of fetal distress and providing appro-
priate surveillance for identified risk factors theoretically
encourages appropriate use of interventions, including
induction of labour, Caesarean section, and pharmaco-
logical treatment, to prevent fetal loss and adverse mater-
nal or neonatal outcomes. Screening and monitoring are
futile, however, in the absence of effective interventions to
act promptly and appropriately to manage identified risk
factors and complications. The weak evidence in this
review for impact of screening and monitoring interven-
tions on stillbirth incidence is due at least in part to limi-
tations in study designs that result in uninterpretable data.
Screening tests may be ineffective, inappropriate, or occur
too late to prevent adverse outcomes, but more problem-
atically, most studies did not report the impact of inter-
vention (particularly standardised intervention)
following positive screening test results. Effective inter-
ventions exist to prevent stillbirth associated with many
maternal infections or conditions (e.g., syphilis, malaria,
pre-eclampsia) and placental dysfunction (e.g., oligohy-
dramnios, placental insufficiency, abruption). Because
screening and monitoring techniques during pregnancy
also pose the risk of inappropriate or unnecessary use of
drugs, induction of labour, iatrogenic preterm birth, or
Caesarean section, it is practically, ethically, and econom-
ically important to validate the sensitivity, specificity, and
positive predictive value of available screening and moni-
toring techniques to protect women and their babies from
iatrogenic harm; and to ensure the wise use of scarce med-
ical resources in low- and middle-income settings.
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